355 Telomerase gene rescue promotes hepatocarcinogenesis in the context of p53- and telomere-dysfunction by limiting chromosomal instability (English)
- New search for: Lechel, A.
- New search for: Holstege, H.
- New search for: Begus, Y.
- New search for: Schienke, A.
- New search for: Kamino, K.
- New search for: Geffers, R.
- New search for: Lehmann, U.
- New search for: Buer, J.
- New search for: Manns, M. P.
- New search for: Kubicka, S.
- New search for: Lechel, A.
- New search for: Holstege, H.
- New search for: Begus, Y.
- New search for: Schienke, A.
- New search for: Kamino, K.
- New search for: Geffers, R.
- New search for: Lehmann, U.
- New search for: Buer, J.
- New search for: Manns, M. P.
- New search for: Kubicka, S.
In:
JOURNAL OF HEPATOLOGY
;
44
;
S135-S136
;
2006
-
ISSN:
- Article (Journal) / Print
-
Title:355 Telomerase gene rescue promotes hepatocarcinogenesis in the context of p53- and telomere-dysfunction by limiting chromosomal instability
-
Contributors:Lechel, A. ( author ) / Holstege, H. ( author ) / Begus, Y. ( author ) / Schienke, A. ( author ) / Kamino, K. ( author ) / Geffers, R. ( author ) / Lehmann, U. ( author ) / Buer, J. ( author ) / Manns, M. P. ( author ) / Kubicka, S. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 44 ; S135-S136
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2006-01-01
-
Size:S135-S136
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 44
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: Is adefovir dipivoxil the answer?Thio, C. L. et al. | 2006
- 4
-
Treating patients with HCV genotype 1 and low viraemia: More than meets the eyeCraxi, A. / Camma, C. et al. | 2006
- 8
-
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipientsVarela, M. / Bruix, J. et al. | 2006
- 11
-
Fifth Forum on Liver TransplantationClavien, P. A. et al. | 2006
- 13
-
"Will all liver transplantation patients eventually die from cancer?"Sanchez, W. / Talwalkar, J. A. / Gores, G. J. et al. | 2006
- 19
-
Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?Aucejo, F. / Rofaiel, G. / Miller, C. et al. | 2006
- 23
-
What is the current treatment of PTLD after liver transplantation?Dufour, J. F. / Fey, M. F. et al. | 2006
- 27
-
Skin cancers after liver transplantation: What to do?Euvrard, S. / Kanitakis, J. et al. | 2006
- 32
-
Should we screen for colorectal cancer in liver transplantation?Delco, F. / Mullhaupt, B. et al. | 2006
- 39
-
Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in TaiwanLiu, C. J. / Lo, S. C. / Kao, J. H. / Tseng, P. T. / Lai, M. Y. / Ni, Y. H. / Yeh, S. H. / Chen, P. J. / Chen, D. S. et al. | 2006
- 47
-
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapyBrau, N. / Salvatore, M. / Rios-Bedoya, C. F. / Fernandez-Carbia, A. / Paronetto, F. / Rodriguez-Orengo, J. F. / Rodriguez-Torres, M. / for, t. P. et al. | 2006
- 56
-
Ophthalmologic side effects during alpha-interferon therapy for viral hepatitisdAlteroche, L. / Majzoub, S. / Lecuyer, A. I. / Delplace, M. P. / Bacq, Y. et al. | 2006
- 62
-
Safety and efficacy of adefovir dipivoxil in patients infectedwith lamivudine-resistant hepatitis B and HIV-1Benhamou, Y. / Thibault, V. / Vig, P. / Calvez, V. / Marcelin, A. G. / Fievet, M. H. / Currie, G. / Chang, C. G. / Biao, L. / Xiong, S. et al. | 2006
- 68
-
A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 casesYamada, H. / Ebara, M. / Yamaguchi, T. / Okabe, S. / Fukuda, H. / Yoshikawa, M. / Kishimoto, T. / Matsubara, H. / Hachiya, H. / Ishikura, H. et al. | 2006
- 76
-
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapyChen, C. H. / Lee, C. M. / Lu, S. N. / Changchien, C. S. / Wang, J. C. / Wang, J. H. / Hung, C. H. / Hu, T. H. et al. | 2006
- 83
-
Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapseGerotto, M. / Dal Pero, F. / Bortoletto, G. / Ferrari, A. / Pistis, R. / Sebastiani, G. / Fagiuoli, S. / Realdon, S. / Alberti, A. et al. | 2006
- 88
-
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patientsMcHutchison, J. G. / Patel, K. / Pockros, P. / Nyberg, L. / Pianko, S. / Yu, R. Z. / Andrew Dorr, F. / Kwoh, T. J. et al. | 2006
- 97
-
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaZeuzem, S. / Buti, M. / Ferenci, P. / Sperl, J. / Horsmans, Y. / Cianciara, J. / Ibranyi, E. / Weiland, O. / Noviello, S. / Brass, C. et al. | 2006
- 104
-
Neuropsychological abnormalities in cirrhosis include learning impairmentOrtiz, M. / Cordoba, J. / Jacas, C. / Flavia, M. / Esteban, R. / Guardia, J. et al. | 2006
- 111
-
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosisNagula, S. / Jain, D. / Groszmann, R. J. / Garcia-Tsao, G. et al. | 2006
- 118
-
Cadaveric full-size liver transplantation and the graft alternatives in adults: A comparative study from a single centreSebagh, M. / Yilmaz, F. / Karam, V. / Falissard, B. / Ichai, P. / Roche, B. / Castaing, D. / Guettier, C. / Samuel, D. / Azoulay, D. et al. | 2006
- 126
-
Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinomaLie-A-Ling, M. / Bakker, C. T. / Deurholt, T. / Hoekstra, R. / Wesseling, J. G. / Afford, S. C. / Bosma, P. J. et al. | 2006
- 134
-
Characterization of acute liver failure and development of a continuous risk of death staging system in childrenLiu, E. / MacKenzie, T. / Dobyns, E. L. / Parikh, C. R. / Karrer, F. M. / Narkewicz, M. R. / Sokol, R. J. et al. | 2006
- 142
-
Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinomaWada, A. / Fukui, K. / Sawai, Y. / Imanaka, K. / Kiso, S. / Tamura, S. / Shimomura, I. / Hayashi, N. et al. | 2006
- 151
-
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapySieghart, W. / Losert, D. / Strommer, S. / Cejka, D. / Schmid, K. / Rasoul-Rockenschaub, S. / Bodingbauer, M. / Crevenna, R. / Monia, B. P. / Peck-Radosavljevic, M. et al. | 2006
- 158
-
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based studyEl-Serag, H. B. / Siegel, A. B. / Davila, J. A. / Shaib, Y. H. / Cayton-Woody, M. / McBride, R. / McGlynn, K. A. et al. | 2006
- 167
-
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long termNeef, M. / Ledermann, M. / Saegesser, H. / Schneider, V. / Widmer, N. / Decosterd, L. A. / Rochat, B. / Reichen, J. et al. | 2006
- 176
-
Limited iron export by hepatocytes contributes to hepatic iron-loading in the Hfe knockout mouseChua, A. C. / Drake, S. F. / Herbison, C. E. / Olynyk, J. K. / Leedman, P. J. / Trinder, D. et al. | 2006
- 183
-
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranesVay, D. / Rigamonti, C. / Vidali, M. / Mottaran, E. / Alchera, E. / Occhino, G. / Sartori, M. / Albano, E. et al. | 2006
- 190
-
Hepatic steatosis and insulin resistance: Does etiology make a difference?Lonardo, A. / Lombardini, S. / Scaglioni, F. / Carulli, L. / Ricchi, M. / Ganazzi, D. / Adinolfi, L. E. / Ruggiero, G. / Carulli, N. / Loria, P. et al. | 2006
- 197
-
Non-alcoholic steatohepatitis: From cell biology to clinical practiceCortez-Pinto, H. / de Moura, M. C. / Day, C. P. et al. | 2006
- 209
-
Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesisLanger, D. A. / Shah, V. H. et al. | 2006
- 217
-
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesDAmico, G. / Garcia-Tsao, G. / Pagliaro, L. et al. | 2006
- 232
-
Canalicular membrane localization of hepatocyte aquaporin-8 is preserved in estradiol-17b-d-glucuronide-induced cholestasisMottino, A. D. / Carreras, F. I. / Gradilone, S. A. / Marinelli, R. A. / Vore, M. et al. | 2006
- 233
-
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesisTanaka, S. / Wands, J. R. / Arii, S. et al. | 2006
- 236
-
Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitisTakagi, H. / Hagiwara, S. / Hashizume, H. / Kanda, D. / Sato, K. / Sohara, N. / Kakizaki, S. / Takahashi, H. / Mori, M. / Kaneko, H. et al. | 2006
- 240
-
A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2Lam, C. W. / Cheung, K. M. / Tsui, M. S. / Yan, M. S. / Lee, C. Y. / Tong, S. F. et al. | 2006
- 243
-
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicinEllis, E. / Wagner, M. / Lammert, F. / Nemeth, A. / Gumhold, J. / Strassburg, C. P. / Kylander, C. / Katsika, D. / Trauner, M. / Einarsson, C. et al. | 2006
- 246
-
Digestive endoscopy and HCV transmissionBronowicki, J. P. et al. | 2006
- 248
-
Announcements| 2006
- 249
-
Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?Kloppel, G. / Kosmahl, M. et al. | 2006
- 251
-
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A foray across diagnostic boundariesCzaja, A. J. et al. | 2006
- 253
-
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?Larter, C. Z. / Farrell, G. C. et al. | 2006
- 262
-
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problemsTsui, J. I. / Pletcher, M. J. / Vittinghoff, E. / Seal, K. / Gonzales, R. et al. | 2006
- 267
-
Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replicationTakehara, T. / Suzuki, T. / Ohkawa, K. / Hosui, A. / Jinushi, M. / Miyagi, T. / Tatsumi, T. / Kanazawa, Y. / Hayashi, N. et al. | 2006
- 275
-
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naive patients with chronic hepatitis C genotype 1 infectionFerenci, P. / Formann, E. / Laferl, H. / Gschwantler, M. / Hackl, F. / Brunner, H. / Hubmann, R. / Datz, C. / Stauber, R. / Steindl-Munda, P. et al. | 2006
- 283
-
Virologic response and resistance to adefovir in patients with chronic hepatitis BFung, S. K. / Chae, H. B. / Fontana, R. J. / Conjeevaram, H. / Marrero, J. / Oberhelman, K. / Hussain, M. / Lok, A. S. et al. | 2006
- 291
-
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot studyCornberg, M. / Hadem, J. / Herrmann, E. / Schuppert, F. / Schmidt, H. H. / Reiser, M. / Marschal, O. / Steffen, M. / Manns, M. P. / Wedemeyer, H. et al. | 2006
- 302
-
Significance of liver negative-strand HCV RNA quantitation in chronic hepatitis CYuki, N. / Matsumoto, S. / Tadokoro, K. / Mochizuki, K. / Kato, M. / Yamaguchi, T. et al. | 2006
- 310
-
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor respondersBerzigotti, A. / Rinaldi, M. F. / Magalotti, D. / Morelli, M. C. / Zappoli, P. / Andreone, P. / Rossi, C. / Zoli, M. et al. | 2006
- 317
-
Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigsLi, L. J. / Du, W. B. / Zhang, Y. M. / Li, J. / Pan, X. P. / Chen, J. J. / Cao, H. C. / Chen, Y. / Chen, Y. M. et al. | 2006
- 325
-
Hepatic gene induction in murine bone marrow after hepatectomyYamazaki, S. / Miki, K. / Takayama, T. / Hasegawa, K. / Sata, M. / Midorikawa, Y. / Aburatani, H. / Makuuchi, M. et al. | 2006
- 334
-
Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cellsDahlke, M. H. / Loi, R. / Warren, A. / Holz, L. / Popp, F. C. / Weiss, D. J. / Piso, P. / Bowen, D. G. / McCaughan, G. W. / Schlitt, H. J. et al. | 2006
- 342
-
Interferon-a enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cellsLiedtke, C. / Groger, N. / Manns, M. P. / Trautwein, C. et al. | 2006
- 350
-
Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasisZen, Y. / Sasaki, M. / Fujii, T. / Chen, T. C. / Chen, M. F. / Yeh, T. S. / Jan, Y. Y. / Huang, S. F. / Nimura, Y. / Nakanuma, Y. et al. | 2006
- 359
-
Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicityHanson, J. C. / Bostick, M. K. / Campe, C. B. / Kodali, P. / Lee, G. / Yan, J. / Maher, J. J. et al. | 2006
- 368
-
Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species contentPallottini, V. / Martini, C. / Bassi, A. M. / Romano, P. / Nanni, G. / Trentalance, A. et al. | 2006
- 375
-
Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in ratsHsu, M. K. / Qiao, L. / Ho, V. / Zhang, B. H. / Zhang, H. / Teoh, N. / Dent, P. / Farrell, G. C. et al. | 2006
- 383
-
Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient miceLorena, D. / Darby, I. A. / Gadeau, A. P. / Lam Shang Leen, L. / Rittling, S. / Porto, L. C. / Rosenbaum, J. / Desmouliere, A. et al. | 2006
- 391
-
Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytesTroadec, M. B. / Courselaud, B. / Detivaud, L. / Haziza-Pigeon, C. / Leroyer, P. / Brissot, P. / Loreal, O. et al. | 2006
- 400
-
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndromeChazouilleres, O. / Wendum, D. / Serfaty, L. / Rosmorduc, O. / Poupon, R. et al. | 2006
- 407
-
Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemiaDe Bruyne, R. / Portmann, B. / Samyn, M. / Bansal, S. / Knisely, A. / Mieli-Vergani, G. / Dhawan, A. et al. | 2006
- 411
-
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practiceMcHutchison, J. G. / Bartenschlager, R. / Patel, K. / Pawlotsky, J. M. et al. | 2006
- 422
-
Cellular and virological mechanisms of HBV drug resistanceLocarnini, S. / Mason, W. S. et al. | 2006
- 432
-
Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemiaBruchfeld, A. / Lindahl, K. / Stahle, L. / Schvarcz, R. et al. | 2006
- 433
-
ReplyMazzaro, C. / Rossi, P. / Pozzato, G. et al. | 2006
- 433
-
Effect of correcting transferrin saturation for body mass index in HFE C282Y homozygotesWaalen, J. / Beutler, E. et al. | 2006
- 436
-
Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied researchZeisel, M. B. / Baumert, T. F. et al. | 2006
- 441
-
The coming wave of HCV-related liver disease: Dilemmas and challengesPerz, J. F. / Alter, M. J. et al. | 2006
- 444
-
How to assess liver fibrosis and for what purpose?Beaugrand, M. et al. | 2006
- 446
-
Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanismWang, J. / Sun, R. / Wei, H. / Dong, Z. / Gao, B. / Tian, Z. et al. | 2006
- 455
-
Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infectionsDeuffic-Burban, S. / Mohamed, M. K. / Larouze, B. / Carrat, F. / Valleron, A. J. et al. | 2006
- 462
-
Performance of serum marker panels for liver fibrosis in chronic hepatitis CParkes, J. / Guha, I. N. / Roderick, P. / Rosenberg, W. et al. | 2006
- 475
-
Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infectionNisii, C. / Tempestilli, M. / Agrati, C. / Poccia, F. / Tocci, G. / Longo, M. A. / DOffizi, G. / Tersigni, R. / Lo Iacono, O. / Antonucci, G. et al. | 2006
- 484
-
Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)Maynard, M. / Pradat, P. / Bailly, F. / Rozier, F. / Nemoz, C. / Si Ahmed, S. N. / Adeleine, P. / Trepo, C. / a French Multicenter Group, a. et al. | 2006
- 491
-
Depression, anemia and health-related quality of life in chronic hepatitis CDan, A. A. / Martin, L. M. / Crone, C. / Ong, J. P. / Farmer, D. W. / Wise, T. / Robbins, S. C. / Younossi, Z. M. et al. | 2006
- 499
-
Place of residence and distance to medical care influence the diagnosis of hepatitis C: A population-based studyMonnet, E. / Collin-Naudet, E. / Bresson-Hadni, S. / Minello, A. / Di Martino, V. / Carel, D. / Jooste, V. / Gagnaire, A. / Evrard, P. / Obert-Clerc, B. et al. | 2006
- 507
-
The effect of pegylated interferon-a on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infectionLeemans, W. F. / Flink, H. J. / Janssen, H. L. / Niesters, H. G. / Schalm, S. W. / de Man, R. A. et al. | 2006
- 512
-
Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertensionWiest, R. / Jurzik, L. / Moleda, L. / Froh, M. / Schnabl, B. / Horsten, S. v. / Scholmerich, J. / Straub, R. H. et al. | 2006
- 520
-
Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centresMentha, G. / Giostra, E. / Majno, P. E. / Bechstein, W. O. / Neuhaus, P. / OGrady, J. / Praseedom, R. K. / Burroughs, A. K. / Treut, Y. P. / Kirkegaard, P. et al. | 2006
- 529
-
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activationElinav, E. / Abd-Elnabi, A. / Pappo, O. / Bernstein, I. / Klein, A. / Engelhardt, D. / Rabbani, E. / Ilan, Y. et al. | 2006
- 537
-
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in miceWolf, A. M. / Wolf, D. / Avila, M. A. / Moschen, A. R. / Berasain, C. / Enrich, B. / Rumpold, H. / Tilg, H. et al. | 2006
- 544
-
Regulatory effects of tumor necrosis factor-alpha and interleukin-6 on HAMP expression in iron loaded rat hepatocytesDzikaite, V. / Holmstrom, P. / Stal, P. / Eckes, K. / Hagen, K. / Eggertsen, G. / Gafvels, M. / Melefors, O. / Hultcrantz, R. et al. | 2006
- 552
-
Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 responseCabillic, F. / Rougier, N. / Basset, C. / Lecouillard, I. / Quelvennec, E. / Toujas, L. / Guguen-Guillouzo, C. / Corlu, A. et al. | 2006
- 560
-
Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systemsAdrian, J. E. / Poelstra, K. / Scherphof, G. L. / Molema, G. / Meijer, D. K. / Reker-Smit, C. / Morselt, H. W. / Kamps, J. A. et al. | 2006
- 568
-
Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in ratsNamisaki, T. / Yoshiji, H. / Kojima, H. / Yoshii, J. / Ikenaka, Y. / Noguchi, R. / Sakurai, S. / Yanase, K. / Kitade, M. / Yamazaki, M. et al. | 2006
- 576
-
Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damageSlotta, J. E. / Scheuer, C. / Menger, M. D. / Vollmar, B. et al. | 2006
- 586
-
Mice heterozygous for the Mdr2 gene demonstrate decreased PEMT activity and diminished steatohepatitis on the MCD dietIgolnikov, A. C. / Green, R. M. et al. | 2006
- 593
-
HBV drug resistance: Mechanisms, detection and interpretationShaw, T. / Bartholomeusz, A. / Locarnini, S. et al. | 2006
- 607
-
The culture of designing hepato-biliary randomised trialsGluud, C. et al. | 2006
- 616
-
Acute hepatitis associated with the use of green tea infusionsJimenez-Saenz, M. / Martinez-Sanchez, M. d. et al. | 2006
- 617
-
Occult hepatitis B virus infection and transfusionAllain, J. P. et al. | 2006
- 620
-
Risk scores in cirrhotic patients: From non-transplant surgery to transplantation and backDurand, F. et al. | 2006
- 623
-
EASL: A growing association in the global worldPawlotsky, J. M. / EASL, S. S. et al. | 2006
- 624
-
HCV therapy in 2006: Down with ALT levels, in with awareness of co-existent metabolic syndromeHarrison, S. A. et al. | 2006
- 627
-
Immunosuppression and outcomes of patients transplanted for hepatitis CLake, J. R. et al. | 2006
- 630
-
Staging systems for hepatocellular carcinoma: Should we all use the BCLC system?Marrero, J. A. et al. | 2006
- 633
-
Steroids or cocktails for alcoholic hepatitisOShea, R. / McCullough, A. J. et al. | 2006
- 637
-
Sixth Forum on Liver Transplantation. Center approach to liver diseases. Is it worthwhile?Clavien, P. A. et al. | 2006
- 639
-
Do we need a center approach to treat patients with liver diseases?Clavien, P. A. / Mullhaupt, B. / Pestalozzi, B. C. et al. | 2006
- 642
-
Does a liver center make sense from a cost perspective?Delco, F. / Muller, M. J. et al. | 2006
- 647
-
Who should perform liver transplantation? Should that be the transplant surgeon, the hepatobilary surgeon, or the general surgeon?Desai, D. M. / Kuo, P. C. et al. | 2006
- 649
-
Part II: The Hepatobiliary SurgeonBelghiti, J. et al. | 2006
- 652
-
Part III: The General SurgeonSenninger, N. et al. | 2006
- 655
-
Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: The Transplant HepatologistGaglio, P. J. / Brown, R. S. et al. | 2006
- 657
-
Part II: The GastroenterologistMartin, P. et al. | 2006
- 659
-
What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons?Tuttle-Newhall, J. E. / Diehl, A. M. et al. | 2006
- 663
-
Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cellsRen, X. / Luo, G. / Xie, Z. / Zhou, L. / Kong, X. / Xu, A. et al. | 2006
- 671
-
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsBain, V. G. / Kaita, K. D. / Yoshida, E. M. / Swain, M. G. / Heathcote, E. J. / Neumann, A. U. / Fiscella, M. / Yu, R. / Osborn, B. L. / Cronin, P. W. et al. | 2006
- 679
-
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPrati, D. / Shiffman, M. L. / Diago, M. / Gane, E. / Rajender Reddy, K. / Pockros, P. / Farci, P. / OBrien, C. B. / Lardelli, P. / Blotner, S. et al. | 2006
- 686
-
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis CSebastiani, G. / Vario, A. / Guido, M. / Noventa, F. / Plebani, M. / Pistis, R. / Ferrari, A. / Alberti, A. et al. | 2006
- 694
-
Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosisSelzner, N. / Selzner, M. / Jochum, W. / Amann-Vesti, B. / Graf, R. / Clavien, P. A. et al. | 2006
- 702
-
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrenceTisone, G. / Orlando, G. / Cardillo, A. / Palmieri, G. / Manzia, T. M. / Baiocchi, L. / Lionetti, R. / Anselmo, A. / Toti, L. / Angelico, M. et al. | 2006
- 710
-
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized studyLlado, L. / Xiol, X. / Figueras, J. / Ramos, E. / Memba, R. / Serrano, T. / Torras, J. / Garcia-Gil, A. / Gonzalez-Pinto, I. / Castellote, J. et al. | 2006
- 717
-
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionBerenguer, M. / Aguilera, V. / Prieto, M. / San Juan, F. / Rayon, J. M. / Benlloch, S. / Berenguer, J. et al. | 2006
- 723
-
Prospective validation of the Barcelona Clinic Liver Cancer staging systemCillo, U. / Vitale, A. / Grigoletto, F. / Farinati, F. / Brolese, A. / Zanus, G. / Neri, D. / Boccagni, P. / Srsen, N. / DAmico, F. et al. | 2006
- 732
-
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesShiri-Sverdlov, R. / Wouters, K. / Gorp, P. J. / Gijbels, M. J. / Noel, B. / Buffat, L. / Staels, B. / Maeda, N. / Bilsen, M. v. / Hofker, M. H. et al. | 2006
- 742
-
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured ratsOyagi, S. / Hirose, M. / Kojima, M. / Okuyama, M. / Kawase, M. / Nakamura, T. / Ohgushi, H. / Yagi, K. et al. | 2006
- 749
-
Growth and differentiation of colony-forming human hepatocytes in vitroYamasaki, C. / Tateno, C. / Aratani, A. / Ohnishi, C. / Katayama, S. / Kohashi, T. / Hino, H. / Marusawa, H. / Asahara, T. / Yoshizato, K. et al. | 2006
- 758
-
Eve-3: A liver enriched suppressor of Ras/MAPK signalingKing, J. A. / Corcoran, N. M. / DAbaco, G. M. / Straffon, A. F. / Smith, C. T. / Poon, C. L. / Buchert, M. / I, S. / Hall, N. E. / Lock, P. et al. | 2006
- 768
-
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronidesZelcer, N. / Wetering, K. v. / Waart, R. d. / Scheffer, G. L. / Marschall, H. U. / Wielinga, P. R. / Kuil, A. / Kunne, C. / Smith, A. / Valk, M. v. et al. | 2006
- 776
-
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measureNewton, J. L. / Bhala, N. / Burt, J. / Jones, D. E. et al. | 2006
- 784
-
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-A randomised clinical trialPhillips, M. / Curtis, H. / Portmann, B. / Donaldson, N. / Bomford, A. / OGrady, J. et al. | 2006
- 791
-
Clinical characteristics and prognostic markers in disulfiram-induced liver injuryBjornsson, E. / Nordlinder, H. / Olsson, R. et al. | 2006
- 798
-
Molecular prognostication of liver cancer: End of the beginningThorgeirsson, S. S. / Lee, J. S. / Grisham, J. W. et al. | 2006
- 806
-
Ischemic cholangiopathyDeltenre, P. / Valla, D. C. et al. | 2006
- 818
-
Occult HBV infection and blood transfusionPrati, D. / Gerosa, A. / Porretti, L. et al. | 2006
- 819
-
In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?Verma, S. et al. | 2006
- 821
-
6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: Dose or level dependent?Derijks, L. J. / Gilissen, L. P. / de Boer, N. K. / Mulder, C. J. et al. | 2006
- 822
-
Length versus width in liver biopsiesCholongitas, E. / Quaglia, A. / Dhillon, A. P. / Patch, D. / Burroughs, A. K. et al. | 2006
- 823
-
Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimetersGuido, M. / Colloredo, G. / Fassan, M. / Rugge, M. et al. | 2006
- 825
-
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaRumi, M. G. / DAmbrosio, R. / Aghemo, A. et al. | 2006
- 827
-
Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patientsRomero-Gomez, M. / Otero, M. c. / Sanchez-Munoz, D. / Ramirez-Arcos, M. / Larraona, J. L. / Suarez Garcia, E. / Vargas-Romero, J. et al. | 2006
- 829
-
Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosisGriffiths, W. / Davies, S. / Gibbs, P. / Thillainayagam, A. / Alexander, G. et al. | 2006
- 832
-
Angiopoietin-like proteins: Another player in the metabolic fieldGeorge, J. et al. | 2006
- 835
-
Corrigendum to "Resistance to adefovir: A new challenge in the treatment of chronic hepatitis B" [J Hepatol 43 (2005) 920-923]Marcellin, P. / Asselah, T. et al. | 2006
- 837
-
Lets assume that hepatitis C reduces the cardiovascular risk in dialysis patients: Are there practical implications?Cattaneo, D. / Perico, N. / Remuzzi, G. et al. | 2006
- 839
-
The paradox of Epstein-Barr virus-associated hepatitisNegro, F. et al. | 2006
- 842
-
Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytesSchorr, O. / Borel, C. / Trepo, C. / Zoulim, F. / Hantz, O. et al. | 2006
- 848
-
Alterations of leptin during IFN-a therapy in patients with chronic viral hepatitisZografos, T. A. / Rigopoulou, E. I. / Liaskos, C. / Togousidis, E. / Zachou, K. / Gatselis, N. / Germenis, A. / Dalekos, G. N. et al. | 2006
- 856
-
Association between vitamin D receptor, CCR5, TNF-a and TNF-b gene polymorphisms and HBV infection and severity of liver diseaseSuneetha, P. V. / Sarin, S. K. / Goyal, A. / Kumar, G. T. / Shukla, D. K. / Hissar, S. et al. | 2006
- 864
-
Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysisButt, A. A. / Evans, R. / Skanderson, M. / Shakil, A. O. et al. | 2006
- 869
-
Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cellsNaka, K. / Abe, K. i. / Takemoto, K. / Dansako, H. / Ikeda, M. / Shimotohno, K. / Kato, N. et al. | 2006
- 879
-
The role of Epstein-Barr virus in acute and chronic hepatitisDrebber, U. / Kasper, H. U. / Krupacz, J. / Haferkamp, K. / Kern, M. A. / Steffen, H. M. / Quasdorff, M. / zur Hausen, A. / Odenthal, M. / Dienes, H. P. et al. | 2006
- 886
-
Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat liversLoureiro-Silva, M. R. / Iwakiri, Y. / Abraldes, J. G. / Haq, O. / Groszmann, R. J. et al. | 2006
- 894
-
Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat liversVairetti, M. / Richelmi, P. / Berte, F. / Currin, R. T. / Lemasters, J. J. / Imberti, R. et al. | 2006
- 902
-
Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablationPacella, C. M. / Bizzarri, G. / Francica, G. / Forlini, G. / Petrolati, A. / Valle, D. / Anelli, V. / Bianchini, A. / Nuntis, S. D. / Pacella, S. et al. | 2006
- 910
-
Cryopreservation of hepatic stellate cellsNeyzen, S. / Van de Leur, E. / Borkham-Kamphorst, E. / Herrmann, J. / Hollweg, G. / Gressner, A. M. / Weiskirchen, R. et al. | 2006
- 918
-
Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: Involvement of JNK and ERK MAP kinasesConde de la Rosa, L. / Schoemaker, M. H. / Vrenken, T. E. / Buist-Homan, M. / Havinga, R. / Jansen, P. L. / Moshage, H. et al. | 2006
- 930
-
Pyruvate ameliorates the defect in ureogenesis from ammonia in citrin-deficient miceMoriyama, M. / Li, M. X. / Kobayashi, K. / Sinasac, D. S. / Kannan, Y. / Iijima, M. / Horiuchi, M. / Tsui, L. C. / Tanaka, M. / Nakamura, Y. et al. | 2006
- 939
-
Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotidesMartin-Armas, M. / Simon-Santamaria, J. / Pettersen, I. / Moens, U. / Smedsrod, B. / Sveinbjornsson, B. et al. | 2006
- 947
-
The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regenerationvan den Heuvel, M. C. / Gouw, A. S. / Boot, M. / Slooff, M. J. / Poppema, S. / de Jong, K. P. et al. | 2006
- 956
-
Metabolic profiling of livers and blood from obese Zucker ratsSerkova, N. J. / Jackman, M. / Brown, J. L. / Liu, T. / Hirose, R. / Roberts, J. P. / Maher, J. J. / Niemann, C. U. et al. | 2006
- 963
-
Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cellsKannarkat, G. T. / Tuma, D. J. / Tuma, P. L. et al. | 2006
- 971
-
Aspartyl-(asparaginyl)-b-hydroxylase regulates hepatocellular carcinoma invasivenessMonte, S. M. / Tamaki, S. / Cantarini, M. C. / Ince, N. / Wiedmann, M. / Carter, J. J. / Lahousse, S. A. / Califano, S. / Maeda, T. / Ueno, T. et al. | 2006
- 984
-
The role of apoptosis versus oncotic necrosis in liver injury: Facts or faith?Schulze-Bergkamen, H. / Schuchmann, M. / Fleischer, B. / Galle, P. R. et al. | 2006
- 994
-
Cardiac electrophysiological abnormalities in patients with cirrhosisZambruni, A. / Trevisani, F. / Caraceni, P. / Bernardi, M. et al. | 2006
- 1003
-
Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosisThorstensen, K. / Asberg, A. et al. | 2006
- 1005
-
Primary sclerosing cholangitis can present with acute liver failure: Report of two casesBergquist, A. / Glaumann, H. / Lindberg, B. / Broome, U. et al. | 2006
- 1009
-
Fighting viral hepatitis with small RNAsWill, H. / Grundhoff, A. et al. | 2006
- 1013
-
Risk factors for hepatocellular carcinoma in HCV-cirrhosis: What we know and what is missingFattovich, G. / Llovet, J. M. et al. | 2006
- 1017
-
Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cellsGonzalez-Carmona, M. A. / Schussler, S. / Serwe, M. / Alt, M. / Ludwig, J. / Sproat, B. S. / Steigerwald, R. / Hoffmann, P. / Quasdorff, M. / Schildgen, O. et al. | 2006
- 1026
-
Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infectionGaslightwala, I. / Bini, E. J. et al. | 2006
- 1033
-
Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive ratsAngermayr, B. / Mejias, M. / Gracia-Sancho, J. / Garcia-Pagan, J. C. / Bosch, J. / Fernandez, M. et al. | 2006
- 1040
-
Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertensionAndreu, V. / Garcia-Pagan, J. C. / Lionetti, R. / Piera, C. / Abraldes, J. G. / Bosch, J. et al. | 2006
- 1046
-
In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: A comparative study to HGFKhai, N. C. / Takahashi, T. / Ushikoshi, H. / Nagano, S. / Yuge, K. / Esaki, M. / Kawai, T. / Goto, K. / Murofushi, Y. / Fujiwara, T. et al. | 2006
- 1055
-
Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytesMeng, F. / Yamagiwa, Y. / Ueno, Y. / Patel, T. et al. | 2006
- 1066
-
Cholangiocarcinoma and Clonorchis sinensis infection: A case-control study in KoreaChoi, D. / Lim, J. H. / Lee, K. T. / Lee, J. K. / Choi, S. H. / Heo, J. S. / Jang, K. T. / Lee, N. Y. / Kim, S. / Hong, S. T. et al. | 2006
- 1074
-
A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteinsNishikawa, T. / Nakajima, T. / Moriguchi, M. / Jo, M. / Sekoguchi, S. / Ishii, M. / Takashima, H. / Katagishi, T. / Kimura, H. / Minami, M. et al. | 2006
- 1083
-
Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failureChatauret, N. / Desjardins, P. / Zwingmann, C. / Rose, C. / Rao, K. V. / Butterworth, R. F. et al. | 2006
- 1089
-
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohortsIkeda, K. / Arase, Y. / Saitoh, S. / Kobayashi, M. / Someya, T. / Hosaka, T. / Akuta, N. / Suzuki, Y. / Suzuki, F. / Sezaki, H. et al. | 2006
- 1098
-
Hepatic stellate cells do not derive from the neural crestCassiman, D. / Barlow, A. / Vander Borght, S. / Libbrecht, L. / Pachnis, V. et al. | 2006
- 1105
-
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure miceNguyen, J. H. / Yamamoto, S. / Steers, J. / Sevlever, D. / Lin, W. / Shimojima, N. / Castanedes-Casey, M. / Genco, P. / Golde, T. / Richelson, E. et al. | 2006
- 1115
-
The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitroKoenig, S. / Krause, P. / Drabent, B. / Schaeffner, I. / Christ, B. / Schwartz, P. / Unthan-Fechner, K. / Probst, I. et al. | 2006
- 1125
-
Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytesAndriopoulos, B. / Pantopoulos, K. et al. | 2006
- 1132
-
Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host diseaseSato, T. / Habtezion, A. / Beilhack, A. / Schulz, S. / Butcher, E. / Thorlacius, H. et al. | 2006
- 1141
-
Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediatedNelson, L. / Vergnolle, N. / DMello, C. / Chapman, K. / Le, T. / Swain, M. G. et al. | 2006
- 1150
-
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancyVallejo, M. / Briz, O. / Serrano, M. A. / Monte, M. J. / Marin, J. J. et al. | 2006
- 1158
-
Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated ratsSvegliati-Baroni, G. / Ghiselli, R. / Marzioni, M. / Alvaro, D. / Mocchegiani, F. / Saccomanno, S. / Sisti, V. / Ugili, L. / Orlando, F. / Alpini, G. et al. | 2006
- 1167
-
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2Haukeland, J. W. / Damas, J. K. / Konopski, Z. / Loberg, E. M. / Haaland, T. / Goverud, I. / Torjesen, P. A. / Birkeland, K. / Bjoro, K. / Aukrust, P. et al. | 2006
- 1175
-
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver diseaseThabut, D. / Naveau, S. / Charlotte, F. / Massard, J. / Ratziu, V. / Imbert-Bismut, F. / Cazals-Hatem, D. / Abella, A. / Messous, D. / Beuzen, F. et al. | 2006
- 1186
-
From viral pathobiology to the treatment of hepatitis B virus infection EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005)Craxi, A. / Yurdaydn, C. et al. | 2006
- 1196
-
`Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesisLonardo, A. / Carani, C. / Carulli, N. / Loria, P. et al. | 2006
- 1208
-
Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasisBihl, F. / Emmenegger, U. / Reichen, J. / Neftel, K. A. / Zimmermann, A. / Cerny, A. et al. | 2006
- 1213
-
The expanding role of the bile acid receptor FXR in the small intestineCariou, B. / Staels, B. et al. | 2006
- I
-
Guide for Authors| 2006
- III
-
Volume Contents| 2006
- S2
-
Therapeutic management of hepatitis and HIV infection in co-infected patients: Results of a survey performed before the 2005 Consensus ConferenceSalmon, D. / Robain, M. / Rockstroh, J. K. / Benhamou, Y. et al. | 2006
- S6
-
Epidemiology of viral hepatitis and HIV co-infectionAlter, M. J. et al. | 2006
- S6
-
10 Directed evolution of novel gene shuffled interferon alphas for the treatment of hepatitis CBrideau-Andersen, A. / Huang, X. / Chang Sun, S. / Chen, T. / Stark, D. / Sas, I. / Dawes, G. / Zadik, L. / Guptill, D. / Yang, S. et al. | 2006
- S8
-
15 Redistribution of intrahepatic NKT regulatory lymphocytes via administration of beta glycolipids: A possible role for the liver in the alleviation of immune-mediated disordersLalazar, G. / Preston, S. / Eliakim, N. / Pappo, O. / Zolotarov, L. / Ilan, Y. et al. | 2006
- S10
-
Virology of hepatitis B and C viruses and antiviral targetsPawlotsky, J. M. et al. | 2006
- S11
-
23 Nadolol+Isosorbide-5-mononitrate (NAD+ISMN) vs NAD+ISMN + endoscopic band ligation in the prevention of rebleeding in patients with cirrhosis. Preliminary results of a multicenter RCTGarcia-Pagan, J. C. / Villanueva, C. / Albillos, A. / Bañ / ares, R. / Planas, R. / Casado, M. / Bosch, J. et al. | 2006
- S12
-
26 Expression profiling and CGH array as prognostic tools in hepatoblastomaArmengol, C. / Cairo, S. / Fabre, M. / Renard, C. A. / Buendia, M. A. et al. | 2006
- S14
-
Influence of HIV co-infection on hepatitis C immunopathogenesisKoziel, M. J. et al. | 2006
- S14
-
31 Hepatitis B virus infection is dependent on a multistep attachment and entry process mediated by the preS1 and the S-domainGlebe, D. / Gruen, S. / Bulavaite, A. / Sasnauskas, K. / Gerlich, W. H. et al. | 2006
- S15
-
34 Detectable HBV-specific T cell responses in liver transplant recipients: A comparison to chronic hepatitis BLoggi, E. / Bihl, F. K. / Chisholm, J. V. / Testa, L. / Cursaro, C. / Biselli, M. / Pinna, A. D. / Bernardi, M. / Brander, C. / Andreone, P. et al. | 2006
- S16
-
37 Gene therapy of chronic hepatitis B infection using a high-capacity adenovirus expressing interleukin 12 under the control of a liver specific mifepristone-inducible promoterCrettaz, J. / Ochoa, L. / Pañ / eda, A. / Olagü / e, C. / Vales, A. / Kochanek, S. / Prieto, J. / Gonzalez-Aseguinolaza, G. et al. | 2006
- S19
-
Natural history and predictors of disease severity in chronic hepatitis CMassard, J. / Ratziu, V. / Thabut, D. / Moussalli, J. / Lebray, P. / Benhamou, Y. / Poynard, T. et al. | 2006
- S20
-
43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis BZhao, H. / Si, C. W. / Wei, L. / Wan, M. B. / Ying, Y. K. / Hou, J. L. / Niu, J. Q. / Wang, G. Q. / Masashi, M. et al. | 2006
- S21
-
45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)Shouval, D. / Akarca, U. S. / Hatzis, G. / Kitis, G. / Lai, C. L. / Cheinquer, H. / Chang, T. T. / Zink, R. / Zhu, J. / Brett-Smith, H. et al. | 2006
- S23
-
50 Durability of response and occurrence of late response to peginterferon alpha-2a (40KD) [PEGASYS] one year post-treatment in patients with HBeAg-positive chronic hepatitis BLau, G. K. / Piratvisuth, T. / Luo, K. X. / Marcellin, P. / Thongsawat, S. / Cooksley, G. / Gane, E. / Fried, M. W. / Popescu, M. / Wu, J. et al. | 2006
- S24
-
52 A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysisChan, H. L. / Lai, C. L. / Cho, M. / Heathcote, J. / Moon, Y. M. / Chao, Y. C. / Myers, R. / Minuk, G. / Marcellin, P. / Jeffers, L. et al. | 2006
- S25
-
Influence of viral hepatitis on HIV infectionRockstroh, J. K. et al. | 2006
- S27
-
60 Analysis of HBV-specific T-cell responses in patients with occult HBV infectionZerbini, A. / Pilli, M. / Boni, C. / Fisicaro, P. / Penna, A. / Laccabue, D. / Di Vincenzo, P. / Giuberti, T. / Raffa, G. / Pollicino, T. et al. | 2006
- S28
-
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infectionVallet-Pichard, A. / Pol, S. et al. | 2006
- S28
-
63 Hepatic expression of the forkhead transcription factor foxO1 is increased in non-alcoholic steatohepatitis and associated with gluconeogenesis and insulin resistanceValenti, L. / Rametta, R. / Fracanzani, A. L. / Dongiovanni, P. / Fargion, S. et al. | 2006
- S30
-
68 Long-term low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in bile duct-ligated rats with advanced liver fibrosisNeef, M. / Ledermann, M. / Saegesser, H. / Schneider, V. / Reichen, J. et al. | 2006
- S31
-
71 The oncolytic adenovirus ADP53DPR replicates selectively in p53 altered tumor cells and potential tumor spectrum is not limited by the p73 statusKuehnel, F. / Wirth, T. C. / Zender, L. / Manns, M. P. / Kubicka, S. et al. | 2006
- S35
-
HCV virological assessmentForns, X. / Costa, J. et al. | 2006
- S37
-
84 P75 neurotrophin receptor promotes liver regeneration via regulation of hepatic stellate cell differentiationPassino, M. A. / Sikorski, S. L. / Akassoglou, K. et al. | 2006
- S39
-
89 Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease: A case control studyFracanzani, A. L. / Burdick, L. / Rasselli, S. / Pedotti, P. / Grigore, L. / Santorelli, G. / Valenti, L. / Maraschi, A. / Catapano, A. / Fargion, S. et al. | 2006
- S40
-
91 Survival and causes of death in patients with elevated liver enzymes associated with non-alcoholic fatty liver disease (NAFLD)Ekstedt, M. / Franzé / n, L. E. / Mathiesen, U. L. / Holmqvist, M. / Bodemar, G. / Kechagias, S. et al. | 2006
- S40
-
Options for treatment of hepatitis C in HIV-infected personsThomas, D. L. et al. | 2006
- S42
-
96 Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD)Torrice, A. / Alvaro, D. / Onori, P. / Franchitto, A. / Mancino, M. G. / Alpini, G. / Jefferson, D. M. / Angelico, M. / Strazzabosco, M. / Attili, A. F. et al. | 2006
- S43
-
99 Expression of cytoprotective genes in livers and hepatocellular carcinomas, and contribution of heme oxygenase 1 to drug resistanceSass, G. / Ocker, M. / Leukel, P. / Hashemolhosseini, S. / Tiegs, G. et al. | 2006
- S44
-
Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidatesSoriano, V. et al. | 2006
- S45
-
104 Cardiotrophin-1 is an essential factor in the natural defense of the liver against fas-induced cell deathMarqué / s, J. M. / Prieto, J. / Bustos, M. et al. | 2006
- S46
-
107 Transplantation of endothelial progenitor cells improves carbon tetrachloride (CCL4)-induced liver cirrhosis in ratsNakamura, T. / Torimura, T. / Sakamoto, M. / Taniguchi, E. / Hashimoto, O. / Inoue, K. / Sakata, R. / Ueno, T. / Sata, M. et al. | 2006
- S49
-
Treatment algorithm for the management of hepatitis C in HIV-coinfected personsSulkowski, M. S. et al. | 2006
- S53
-
118 Alginate-encapsulated HEPG2 cells in a pilot-scale fluidised bed bioreactor maintain performance in human liver failure plasma making them suitable for use in a bioartificial liverCoward, S. M. / Legallais, C. / Thomas, M. / Tofteng, F. / Larsen, F. / Hodgson, H. J. / Selden, C. et al. | 2006
- S56
-
Assessment of efficacy of treatment in HCV: Infection and diseaseChung, R. T. et al. | 2006
- S56
-
127 Liver transplantation for HCV-alcohol aetiology: Is the outcome similar to those to HCV or alcohol alone?Aguilera, V. / Berenguer, M. / Benlloch, S. / Prieto, M. / Berenguer, J. et al. | 2006
- S57
-
130 Applicability and safety of extracorporeal liver support using albumin dialysis (MARS) in the setting of liver transplantationCatalina, M. V. / Ripoll, C. / Clemente, G. / Salcedo, M. / Rincon, D. / Matilla, A. / Nuñ / ez, O. / Beceiro, I. / Lo Iacono, O. et al. | 2006
- S58
-
133 Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progressionCholongitas, E. / Quaglia, A. / Samonakis, D. / Papatheodoridis, G. V. / Senzolo, M. / Triantos, C. / Patch, D. / Dhillon, A. P. / Burroughs, A. K. et al. | 2006
- S60
-
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patientsButi, M. / Wong, J. / Casado, M. A. / Esteban, R. et al. | 2006
- S61
-
142 Prognostic value of actin-free GC-globulin in children with acute liver failureHind, J. / Hussain, M. J. / Cheeseman, P. / Dhawan, A. / Vergani, D. / Mieli-Vergan, G. et al. | 2006
- S62
-
145 Budd-Chiari syndrome (BCS): The Edinburgh experienceKochar, N. / Griffin, S. P. / Ferguson, J. W. / Redhead, D. N. / Finlayson, N. D. / Hayes, P. C. et al. | 2006
- S63
-
148 Clinical features and outcome of hepatic failure associated with Epstein-Barr virus infectionLim, Y. S. / Kim, D. K. / Kim, K. M. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006
- S64
-
151 Transplantation of HBsAg-positive livers: A suitable option for all HBV positive recipients? A single center experienceMontalbano, M. / De Caro, G. / Volpes, R. / Minervini, M. I. / Gridelli, B. et al. | 2006
- S65
-
Natural history of chronic hepatitis B in co-infected patientsPuoti, M. / Torti, C. / Bruno, R. / Filice, G. / Carosi, G. et al. | 2006
- S67
-
159 Introduction and persistence of type III hepatitis a strain in FranceMackiewicz, V. / Roque-Afonso, A. M. / Cotterel, B. / Lebraud, P. / Santa-Ollala, P. / Delarocque-Astagneau, E. / Dussaix, E. et al. | 2006
- S68
-
162 HIV infected patients listed for liver transplantation have shorter intention-to-treat survival than non-infected patientsSanz, C. / Salcedo, M. / Berenguer, J. / Rincon, D. / Miralles, P. / Nogales, O. / Yepes, I. / Nuñ / ez, O. / Clemente, G. et al. | 2006
- S69
-
165 Evaluation of four prognostic scores in patients with acute-on-chronic liver failureStauber, R. E. / Stadlbauer, V. / Struber, G. / Kaufmann, P. et al. | 2006
- S70
-
168 Prophylactic intravenous antibiotics do not influence the outcome of acute liver failureHassoun, Z. / Fournier, C. / Tessier, G. / Villeneuve, E. / Villeneuve, J. P. et al. | 2006
- S71
-
HBV virological assessmentHatzakis, A. / Magiorkinis, E. / Haida, C. et al. | 2006
- S73
-
175 Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to β-adrenergic stimulation in cirrhotic ratsEbrahimi, F. / Tavakoh, S. / Hajrasouliha, A. R. / Dehpour, A. R. et al. | 2006
- S74
-
178 Increased neo-angiogenesis and vascular endothelial growth factor (VEGF) protein expression in the lung of cirrhotic miceGeerts, A. M. / Bergiers, S. / Vanheule, E. / Van Vlierberghe, H. / De Vos, M. / Colle, I. et al. | 2006
- S75
-
180 Diffusion tensor and magnetisation transfer imaging of the brain at 3T in patients with cirrhosis and hepatic encephalopathyGrover, V. P. / Counsell, S. J. / Forton, D. M. / Bradford, E. J. / Saxby, B. K. / Thomas, H. C. / Hajnal, J. V. / Taylor-Robinson, S. D. et al. | 2006
- S76
-
183 Losartan in combination therapy of experimental rat liver fibrosis reversalLukivskayales, O. / Patsenker, E. / Popov, Y. / Schuppan, D. / Buko, V. et al. | 2006
- S77
-
186 The involvement of CB1 and VR1 receptors in cardiovascular disturbances of bile-duct ligated ratsMoezi, L. / Gaskari, S. A. / Liu, H. / Li, Y. / Dehpour, A. R. / Lee, S. S. et al. | 2006
- S77
-
Treatment options in HBVCraxi, A. / Antonucci, G. / Camma, C. et al. | 2006
- S78
-
189 Hepatic inflammation increases portal pressure through inhibition of eNOS activity — Potential mechanismsMookerjee, R. P. / Davies, N. A. / Hodges, S. J. / Dalton, R. N. / Turner, C. / Wiesenthal, A. / Schilling, K. / lcking, A. / Sen, S. / Williams, R. et al. | 2006
- S79
-
191 Opposite post translational regulation of endothelial no synthase (ENOS) by heat shock protein 90 and caveolin in liver and lungs from rats with hepatopulmonary syndromePastor, C. M. / Quadri, R. / Hadengue, A. / Cikirikcioglu, B. / Schiffer, E. / Bourquin, J. / Morel, D. / Frossard, J. L. et al. | 2006
- S80
-
194 Cirrhosis reversal by antifibrotic combination therapy: Potentiation of the antifibrotic effect of mycophenolate mofetil by pioglitazone and halofuginonePopov, Y. / Khokhar, A. / Patsenker, E. / Niedobitek, E. / Schuppan, D. et al. | 2006
- S81
-
197 Hepcidin and hemojuvelin gene expression in rat liver damage: In vivo and in vitro studiesSheikh, N. / Tron, K. / Dudas, J. / Saile, B. / Batusic, D. / Ramadori, G. et al. | 2006
- S82
-
200 Derangement of the hepatic microcirculation during the development of liver cirrhosis in the bile duct ligated (BDL) ratFrancis, R. J. / Wheatley, A. M. et al. | 2006
- S83
-
203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized studyAlessandria, C. / Marzano, A. / Ottobrelli, A. / Debemardi-Venon, W. / Todros, L. / Torrani, M. / Morgando, A. / Balzola, E. / Martini, S. / Cacace, G. et al. | 2006
- S84
-
206 Safe use of peg-ifn and ribavirin in hcv-cirrhotic patients undergoing partial splenic embolizationBá / rcena, R. / Moreno, A. / Foruny, J. R. / Quereda, C. / Blazquez, J. / Gil-Grande, L. A. / Moreno, J. / Perez-Elias, M. J. / Antela, A. et al. | 2006
- S84
-
Candidates for therapy: HBVDusheiko, G. et al. | 2006
- S85
-
209 Angiotensin ii type 1 receptors blockade decreases pulmonary vascular resistance in cirrhotic patientsCastano, G. O. / Viudez, P. / Izus, M. / Mesquida, M. / Sookoian, S. et al. | 2006
- S89
-
221 Independent parameters associated with protein-energy malnutrition in cirrhosis: Prospective analysis of 105 patientsHrycewycz, N. / Bureau, C. / Peron, J. M. / Rouquet, O. / Dupuis, E. / Vinel, J. P. et al. | 2006
- S90
-
Treatment algorithm for chronic hepatitis B in HIV-infected patientsBenhamou, Y. et al. | 2006
- S93
-
232 Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathySharma, P. / Sharma, B. C. / Sarin, S. K. / Puri, V. et al. | 2006
- S94
-
235 Non-invasive predictors of advanced fibrosis in genetic haemochromatosis — do practice guidelines change practice?Thomas, J. A. / Watson, A. / Zaitoun, A. / Neal, K. / Gamble, S. / Goddard, W. P. / Long, R. G. / Ryder, S. D. / Aithal, G. P. et al. | 2006
- S95
-
Assessment of treatment efficacy in HBV infection and diseaseZoulim, F. et al. | 2006
- S96
-
240 Des-gamma-carboxy prothrombin-IgM immune complex as novel biomarker for hepatocellular carcinomaBeneduce, L. / Pesce, G. / Gallotta, A. / Fassina, G. et al. | 2006
- S97
-
243 Antioxidant supplements for prevention of liver cancerBjelakovic, G. / Nikolova, D. / Simonetti, R. G. / Gluud, C. et al. | 2006
- S99
-
249 Risk factors and patterns of extrahepatic metastasis of hepatocellular carcinomaChung, W. J. / Lee, H. S. / Kim, S. Y. / Lee, Y. S. / Chung, K. W. / Jang, B. K. / Park, K. S. / Cho, K. B. / Hwang, J. S. / Ahn, S. H. et al. | 2006
- S100
-
Update on HAART in HIVYeni, P. et al. | 2006
- S101
-
254 Effectiveness of radiological techniques in diagnosis of hepatocellular carcinoma. Correlation with liver explantsGarzó / n, M. / Pascasio, J. M. / Sousa, J. M. / Vargas, B. / Castell, E. J. / Gavilá / n, E. / Gó / mez, M. A. et al. | 2006
- S104
-
Prevention of viral hepatitis in HIV co-infectionBrook, G. et al. | 2006
- S108
-
Multiple viral infectionsGaeta, G. B. / Precone, D. F. / Cozzi-Lepri, A. / Cicconi, P. / Monforte, A. D. et al. | 2006
- S108
-
276 Internally cooled versus perfused electrodes for radiofrequency ablation (rfa) in patients with small (≤3 CM) hepatocellular carcinoma (HCC)Seror, O. / Nkontchou, G. / Tin-Tin Htar, M. / Barrucand, C. / Dordera, M. / Ganne-Carrie, N. / Trinchet, J. C. / Sellier, N. / Beaugrand, M. et al. | 2006
- S109
-
279 Novel splicing variant of the vitamin k-dependent γ-glutamyl carboxylase (GGCX) causes des-gamma-carboxyl prothrombin production in human hepatocellular carcinoma cell linesUeda, N. / Shiraha, H. / Fujikawa, T. / Suzuki, M. / Takaoka, N. / Nakanishi, Y. / Takaki, A. / Shiratori, Y. et al. | 2006
- S110
-
282 Modulation of pro-apoptotic p53 transcriptional targeting by bile acids in primary rat hepatocytesAmaral, J. D. / Castro, R. E. / Sola, S. / Rodrigues, C. M. et al. | 2006
- S112
-
288 Undisturbed response to dna damage in telomerase-immortalized human fetal hepatocytesHaker, B. / Knuth, N. / Diedrich, S. / Wege, H. et al. | 2006
- S113
-
291 Proteasome inhibitor induced G2/M arrest through upholding of wee1 kinase in human hepatocellular carcinoma (HCC)Kogiso, T. / Nagahara, H. / Shiratori, K. et al. | 2006
- S114
-
Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their managementMauss, S. et al. | 2006
- S115
-
296 Crosstalk between polyamine oxidation and protective effect of IGF-I in fas-induced acute liver failure: Perspectives for therapeutic interventionPavlovic, D. / Kocic, G. / Stojanovic, I. / Cvetkovic, T. / Jevtovic, T. / Bjelakovic, G. et al. | 2006
- S117
-
303 Hypoxic conformance of metabolism in primary rat hepatocytes: A model of hepatic hibernationSubramanian, R. M. / Chandel, N. / Budinger, S. / Schumacker, P. et al. | 2006
- S119
-
Antiviral hepatitis and antiretroviral drug interactionsPerronne, C. et al. | 2006
- S119
-
308 Coordinated periportal down-regulation of Bsep and Ntcp in experimental cholestasis is associated with induction of periportal Oatp1a4 and Oatp1b2Donner, M. G. / Schumacher, S. / Warskulat, U. / H↑ / ssinger, D. et al. | 2006
- S120
-
311 Regulation of hepatobiliary transporters in response to hypoxiaFouassier, L. / Beaussier, M. / Schiffer, E. / Rey, C. / Lasnier, E. / Scoazec, J. Y. / Lienhart, A. / Barbu, V. / Housset, C. et al. | 2006
- S121
-
314 The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC)Alvaro, D. / Floreani, A. / Onori, P. / Franchitto, A. / Mancino, M. G. / Guido, M. / Carpino, G. / De Santis, A. / Angelico, M. / Attili, A. E. et al. | 2006
- S122
-
317 A distention-contraction reflex in bile canalicular motilityMessner, J. / Reiberger, T. / Marischler, C. / Gajdzik, L. / Graf, J. et al. | 2006
- S123
-
320 3.5-Diethoxycarbonyl-1.4-dihydrocollidine (DDC) feeding induces cholestasis, chronic inflammatory bile duct damage and biliary fibrosis in miceStö / ger, U. / Fickert, E. / Fuchsbichler, A. / Moustafa, T. / Gumhold, J. / Silbert, D. / Zatloukal, K. / Denk, H. / Trauner, M. et al. | 2006
- S124
-
322 A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated ratsAdrian, J. E. / Kamps, J. A. / Scherphof, G. L. / Meijer, D. K. / Poelstra, K. et al. | 2006
- S125
-
325 Endotoxin-induced hsc activation involves pdgfr and egfr recruitmentBrun, P. / Martines, D. / Scarpa, M. / Palú / G. / Castagliuolo, I. et al. | 2006
- S126
-
Assessment of liver fibrosis in co-infected patientsKelleher, T. B. / Afdhal, N. et al. | 2006
- S126
-
328 Reduced cholestatic liver injury in mice deleted for insulin-like growth factor 1 receptor in hepatocytesCadoret, A. / Rey, C. / Wendum, D. / Holzenberger, M. / Housset, C. et al. | 2006
- S127
-
331 Tamoxifen may inhibit hepatic fibrogenesis by suppressing the activation of hepatic stellate cellsKim, J. A. / Chung, Y. H. / Jang, M. K. / Lee, J. K. / Choi, M. H. / Kim, S. H. / Ryu, S. H. / Shin, J. W. / Kim, K. M. / Lim, Y. S. et al. | 2006
- S128
-
334 Ursodeoxycholic acid improves rat liver fibrosis better than spontaneous recoveryMas, M. R. / Tasci, I. / Vural, S. A. / Cornern, B. / Alcigir, G. / Serdar, M. / Mas, N. / Isik, A. T. / Ates, Y. / Uzunalimoglu, O. et al. | 2006
- S129
-
337 Celecoxib, a selective cyclooxygenase-2 inhibitor, shows anti-proliferative, pro-apoptotic and anti-fibrotic effects in human hepatic stellate cellsPaik, Y. H. / Lee, K. S. / Lee, H. J. / Kang, S. H. / Ahn, S. H. / Han, K. H. / Chon, C. Y. / Moon, Y. M. et al. | 2006
- S130
-
340 GPO10, a collagen mimetic effectively promotes activation of collagen-bound pro-matrix-metalloproteinase-2 in fibrotic liver tissueRuehl, M. / Freise, C. / Seja, M. / Erben, U. / Schuppan, D. / Famdale, R. / Zeitz, M. / Somasundaram, R. et al. | 2006
- S131
-
343 MMP-9 overexpression in murine liver: Embryonic lethality and influence on liver homeostasis in juvenile miceThieringer, F. R. / Czochra, E. / Meyer, E. / Schmitt, U. / Anthon, B. / Garcia-Lazaro, J. E. / Lohse, A. W. / Galle, E. R. / Kanzler, S. et al. | 2006
- S132
-
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and managementNunez, M. et al. | 2006
- S133
-
349 Hepatic progenitor cells express VIP receptor type 2Cassiman, D. / De Vos, R. / Sinelli, N. / Vander Borght, S. / Petersen, B. / Bockx, I. / Aertsen, P. / Libbrecht, L. / Nevens, E. / Roskams, T. et al. | 2006
- S134
-
352 Analysis of the homeobox transcription factor Prox-1 expression in rat liver development and in different models of liver damage and regenerationDudas, J. / Elmaouhoub, A. / Mansuroglu, T. / Batusic, D. / Papoutsi, M. / Tron, K. / Saile, B. / Wilting, J. / Ramadori, G. et al. | 2006
- S135
-
355 Telomerase gene rescue promotes hepatocarcinogenesis in the context of p53- and telomere-dysfunction by limiting chromosomal instabilityLechel, A. / Holstege, H. / Begus, Y. / Schienke, A. / Kamino, K. / Geffers, R. / Lehmann, U. / Buer, J. / Manns, M. P. / Kubicka, S. et al. | 2006
- S136
-
358 High expression of claudin-7 during liver regenerationLó / di, C. / Szabo, E. / Batmunkh, E. / Holczbauer, A. / Kiss, A. / Illyé / s, G. / Paku, S. / Schaff, Z. et al. | 2006
- S137
-
360 Platelets promote liver regeneration after extensive hepatectomyMurata, S. / Matsuo, R. / Ikeda, O. / Ohkohchi, N. et al. | 2006
- S140
-
Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT)?Miro, J. M. / Laguno, M. / Moreno, A. / Rimola, A. / the, H. C. et al. | 2006
- S143
-
377 Recombinant viral vectors expressing sodium-iodide symporter for hepatocelllular carcinoma radiotherapyHerve, J. / Sa Cunha, A. / Liu, B. / Longuet, M. / Valogne, Y. / Roux, J. / Boisgard, R. / Tavitian, B. / Clerc, J. / Brechot, C. et al. | 2006
- S145
-
382 Identification of peptides binding to hepatocellular carcinomaShimizu, A. / Maruta, F. / Akita, N. / Miwa, S. / Miyagawa, S. et al. | 2006
- S146
-
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patientsBruno, R. / Puoti, M. / Sacchi, P. / Filice, C. / Carosi, G. / Filice, G. et al. | 2006
- S148
-
391 CD8 T cell hyporesponsiveness in chronic HBV infection: Role of CD3-ZETA downregulationDas, A. / Kennedy, P. / Lopes, A. R. / Dunn, C. / Gilson, R. J. / Bertoletti, A. / Maini, M. K. et al. | 2006
- S149
-
395 Role of circulating IL-10 in acute viral hepatitisNebbia, G. / Northfield, J. / Barnest, E. / Emery, V. / Brown, D. / Willberg, C. / Dusheiko, G. / Klenerman, P. / Fabris, P. et al. | 2006
- S150
-
398 Differential transcriptional responses to interferons in primary liver cells and their modulation by anti-inflammatory cytokinesGrü / newald, P. / Trippler, M. / Wut, J. / Lu, M. / Gerken, G. / Schlaak, J. F. et al. | 2006
- S151
-
401 The functional domain and mechanism of hepatocyte nuclear factor 30 (HNF3β) in inhibition of HBV replicationTang, H. / Huang, E. J. / Hel, F. / Liu, L. / Wang, S. / Liu, E. J. / Zhou, T. Y. / Zhao, L. S. et al. | 2006
- S152
-
404 Detection of HCV-RNA in the liver of anti-HCV positive patients with persistently normal alt levels and serum HCV-RNA negativeCarreñ / o, V. / Pardo, M. / Ló / pez-Alcorocho, J. M. / Rodrí / guez-Iñ / igo, E. / Bartolomé / J. et al. | 2006
- S153
-
407 HCV NS5A protein — functional analysis using a BVDV replicon reporter system shows a correlation between in vitro effects on interferon sensitivity and clinical outcomeJones, M. / Strang, A. L. / Hibbert, L. / Smith, P. L. / Jacobs, M. G. / Foster, G. R. et al. | 2006
- S154
-
410 Modifying effect of hepatitis C virus (HCV) load in naive lymphoid cells on the detection of occult HCV infection following stimulation of the cells with mitogensPham, T. N. / Michalak, T. I. et al. | 2006
- S155
-
413 Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: The camporeale modelArgentini, C. / Genovese, D. / Ferraro, D. / Giordano, V. / Giglio, M. / Taffon, S. / Craxi, A. / Stroffolini, T. / Di Stefano, R. / Ranicetta, M. et al. | 2006
- S156
-
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infectionSagnelli, E. / Argentini, C. / Coppola, N. / Genovese, D. / Pisaturo, M. / Taffon, S. / Sagnelli, C. / Rapicetta, M. et al. | 2006
- S158
-
422 Virus-specific T-cell responses associated with HCV RNA persistence in the liver after apparent recovery from HCV infectionQuiroga, J. A. / Llorente, S. / Castillo, I. / Rodrí / guez-Iñ / igo, E. / Pardo, M. / Carreñ / o, V. et al. | 2006
- S159
-
425 Enhanced apoptosis of CD4+CD25+ T-regulatory lymphocytes in chronic HCV infection: Association with autoimmunityKovalev, Y. / Kessel, A. / Perr, R. / Naschitz, J. E. / Toubi, E. / Zuckerman, E. et al. | 2006
- S160
-
428 T cell chemokine receptor expression and chemotaxis, associated to TH1/TC1 response, in hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV)-HCV co-infectionCalvino, M. / Larrubia, J. R. / Sanz, E. / Pé / rez, J. / Benito, S. / Gonzá / lez, E. / Perna, C. / Montes, M. et al. | 2006
- S161
-
431 Co-inhibitory molecule B7-H1 may play an important role for chronicity of hepatitis CLee, Y. J. / Park, S. J. / Jee, S. R. / Lee, S. H. / Seol, S. Y. / Chung, J. M. / Jeong, H. Y. / Seo, S. K. / Park, S. G. / Cho, I. H. et al. | 2006
- S162
-
434 Detection of a new autoantibody in patients with chronic HCV infectionLiaskos, C. / Bogdanos, D. P. / Norman, G. / Rigopoulou, E. I. / Vergani, D. / Dalekos, G. N. et al. | 2006
- S163
-
437 Intrahepatic NKT and T-regulatory lymphocytes cytokine profile in end stage hepatitis C related chronic liver diseaseMorsy, M. A. / Norman, E. J. / Mitry, R. / Heaton, N. D. / Vaughan, R. W. et al. | 2006
- S164
-
440 Increased TGFβ1 secretion via down-regulating NKG2D killer activator receptor expression results in impaired natural killer cell activity in patients with chronic HCV hepatitisPar, G. / Berki, T. / Palinkas, L. / Szereday, L. / Halasz, M. / Szekeres-Bartho, J. / Miseta, A. / Hegedí / s, G. / Fausts, Z. et al. | 2006
- S165
-
443 Hepatitis C virus promotes angiopoietin-2 expression in liver tissue of patients with chronic hepatitis CSanz-Cameno, P. / Martí / n-Ví / lchez, S. / Borque, M. J. / Moreno-Monteagudo, J. A. / Garcí / a-Buey, L. / Ló / pez-Cabrera, M. et al. | 2006
- S166
-
446 Contribution of auto-immune reactions involving cytochrome P4502E1 to hepatocyte injury during chronic hepatitis CVidali, M. / Occhino, G. / Ivaldi, A. / Serino, R. / Moia, S. / Rigamonti, C. / Sartorie, M. / Albano, E. et al. | 2006
- S167
-
449 Hepatitis C virus structural proteins and activation of Toll-like receptors 2 and 4Hoffmann, M. / Zeisel, M. B. / Barth, H. / Gissler, B. / Jilg, N. / Paranhos-Baccalà / r, G. / Wakita, T. / Golenbock, D. T. / Blum, H. E. et al. | 2006
- S168
-
451 High prevalence of hepatitis B virus infection in B-cell non-hodgkin lymphomaBorentain, P. / Colson, P. / Motte, A. / Moa, V. / Henry, M. / Botta, D. / Tamalet, C. / Gerolami, R. et al. | 2006
- S169
-
455 Prospective comparison of fibroscan and fibrotest in inactive hepatitis B carriersCastera, L. / Foucher, J. / Bernarde, P. H. / Saudo, A. / Bertet, J. / Couzigou, P. / de Ledinghen, V. et al. | 2006
- S170
-
458 HBsAg level in serum and liver in genotype B and C infected chinese chronic hepatitis B patients and their changes under peginterferon-alpha-2a treatmentChen, J. J. / Hou, J. L. / Ma, S. W. / Wang, Z. H. / Zhu, Y. E. / Luo,, K. X. / Naoumov, N. V. et al. | 2006
- S171
-
460 Hepatitis E in rural EnglandDalton, H. R. / Thurairajah, P. / Fellows, H. J. / Hussaini, S. H. / Mitchell, J. / Bendall, R. / Banks, M. / Ijaz, S. / Teo, C. G. / Levine, D. E. et al. | 2006
- S172
-
463 Clinical and virological characteristics of HBeAg-negative patients with chronic hepatitis B in china from 2000 to 2003Hou, J. L. / Yang, C. G. / Yu, L. C. / Chen, J. J. / Sun, J. / Luo, K. X. / Zhu, Y. E. / Guo, Y. B. et al. | 2006
- S173
-
466 Common osteopontin haplotype associated with chronic HBV infection and HCC occurrenceKim, Y. J. / Yoon, J. H. / Lee, H. S. / Park, B. L. / Shin, H. D. et al. | 2006
- S174
-
469 Inactive HBsAg carriers in central Italy. Cross-sectional and initial prospective data of the hep B free observational studyPiccolo, P. / Telesca, C. / Lenci, I. / Di Paolo, D. / Bandiera, E. / De Melia, L. / Sorbello, O. / De Santis, A. / Antonucci, G. / Longo, M. A. et al. | 2006
- S176
-
474 Hepatitis B virus genomic markers for hepatocellular carcinoma on full-genome sequencing of 332 patientsSung, J. J. / Tsui, S. K. / Tse, C. H. / Ng, E. Y. / Leung, K. S. / Lee, K. H. / Mok, T. S. / Bartholomeusz, A. / Au, T. C. / Zhang, M. D. et al. | 2006
- S177
-
477 High rates of hepatitis B virus reverse seroconversion in anti-HBc carriers undergoing allogeneic bone marrow transplantationViganò / M. / Venere, C. / Soligo, D. / Lanfranchi, E. / Lambertenghi Deliliers, G. / Colombo, M. / Lampertico, P. et al. | 2006
- S178
-
480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two yearsBarbon, V. / Marzano, A. / Carenzi, S. / Lagget, M. / Alessandria, C. / Olivero, A. / Gaia, S. / Ciancio, A. / Smedile, A. / Rizzetto, M. et al. | 2006
- S179
-
483 Final analysis of virological outcomes and resistance during 5 years of adefovir dipivoxil monotherapy in HBeAg-negative patientsBorroto-Esoda, K. / Arterburn, S. / Snow, A. / Chuck, S. / Hadziyannis, S. / Locamini, S. / Zoulim, E. / Pawlotsky, J. M. et al. | 2006
- S181
-
488 Virodynamic predictors of treatment response to peginterferon and lamivudine combination treatment of HBeA-positive chronic hepatitis BChan, H. L. / Mihm, U. / Zeuzem, S. / Chim, A. M. / Hui, A. Y. / Wong, V. W. / Sung, J. J. / Herrmann, E. et al. | 2006
- S182
-
491 Peginterferon alpha-2a (40KD) (PEGASYS) reverses cirrhosis, improves fibrosis and slows progression of fibrosis in patients with HBeAg-positive or HBeAg-negative chronic hepatitis B (CHB)Cooksley, G. / Lau, G. K. / Marcellin, P. / Piratvisuth, T. / Bonino, E. / Luo, K. X. / Hadziyannis, S. / Jin, R. / Button, P. / Pluck, N. et al. | 2006
- S183
-
493 Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 yearGane, E. / Lai, C. L. / Liaw, Y. E. / Thongsawat, S. / Wang, Y. / Cheng, Y. / Heathcote, J. / Rasenacks, J. / Bzowej, N. / Naoumov, N. et al. | 2006
- S184
-
495 Tenofovir (TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV)Hann, H. W. / Chae, H. B. / Dunn, S. R. et al. | 2006
- S185
-
498 Efficacy and safety of entecavir in Japanese adult patients with incomplete response to current lamivudine treatment: A phase II clinical trialKarino, Y. / Toyota, J. / Kumada, H. / Katano, Y. / Izumi, N. / Shiratori, Y. / Sata, M. / Seriu, T. / Omata, M. et al. | 2006
- S186
-
501 Lamivudine therapy in children with chronic hepatitis BLiberek, A. / Szaflarska-Poplawska, A. / Korzon, M. / Luczak, G. / Gora-Gebka, M. / Los Rycharska, E. / Balko, W. / Sikorska-Wisniewska, G. / Szlagatys-Sidorkiewicz, A. / Czerwionka-Szaflarska, M. et al. | 2006
- S190
-
512 Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis BYurdaydin, C. / Senturk, H. / Boron-Kaczmarska, A. / Raptopoulou-Gigi, M. / Batur, Y. / Goodmans, Z. / Vaughah, J. / Brett-Smith, H. / Hindes, R. et al. | 2006
- S191
-
515 Non-response and resistance to adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistanceValdes, A. / Buti, M. / Jardi, R. / Rodriguez-Frias, E. / Schaner, M. / Esteban, R. / Guardia, J. et al. | 2006
- S194
-
522 Absence of pharmacokinetic drug-drug interaction between telbivudine and peginterferon alpha-2a or cyclosporine in healthy subjectsZhou, X. J. / Fielman, B. / Dubuc-Patrick, G. / Chao, G. / Brown, N. et al. | 2006
- S195
-
525 Hepatitis virus C RNA quantification by automated cobas ampliprep-cobas taqman 48 (CAP-CTM) real-time PCR assay. An evaluation of performanceChevaliez, S. / Bouvier-Alias, M. / Dameron, G. / Darthuy, E. / Remire, J. / Pawlotsky, J. M. et al. | 2006
- S196
-
528 Performance evaluation of 3 commercially available qunatitative HCV tests in the clinical settingRoudiere, L. / Ottomani, L. / Mondain, A. M. / Perney, P. / Blanc, F. / Larrey, D. / Ducos, J. et al. | 2006
- S199
-
536 Changes in NF-KB activation and iNOS and Mn-SOD gene expression during the progression to hepatocarcinoma in patients with chronic HCV infectionCuevas, M. J. / Almar, M. / Montoya, P. / Lima, E. / Olcoz, J. L. / Gonzalez-Gallego, J. / Jorquera, F. et al. | 2006
- S202
-
544 Accuracy of two new predictive models in assessing fibrosis in chronic hepatitis C (CHC)Paggi, S. / Fraquelli, M. / Conte, D. / Colombo, M. / Viganò / M. / Facciotto, C. / Dal Poggio, P. / Colli, A. et al. | 2006
- S203
-
547 Epidemiology and natural course of hepatitis C in Greece: Results of the nationwide HEPNET Greece cohort studyRantonoulou, M. / Tzoumakliotis, D. / Nikolopoulou, G. / Skoutelis, A. / Dalekos, G. / Dimopoulou, M. / Angelidou, K. / Avgerinos, A. / Chatiis, G. / Manolakopoulos, S. et al. | 2006
- S205
-
552 Angiotensin converting enzyme gene I/D polymorphism and liver fibrosis in chronic hepatitis CSmirne, C. / Fabris, C. / Toniutto, P. / Caldera, F. / Mella, R. / Bitetto, D. / Fumagalli, S. / Rossi, E. / Minisini, R. / Ceriani, E. et al. | 2006
- S206
-
555 Spontaneous resolution of chronic genotype 2 and 3 hepatitis C virus infection after apparently ineffective pegylated interferon and ribavirin therapy. A four-year prospective controlled studyAnnicchiarico, B. E. / Siciliano, M. / Avolio, A. W. / Bombardieri, G. et al. | 2006
- S207
-
558 Risk factors for bacterial infections in HIV/HCV-coinfected patients during interferon plus ribavirin-based therapyBani-Sadr, F. / Carrat, F. / Goderel, I. / Driiss, H. / Pol, S. / Cacoub, P. / Perronne, C. et al. | 2006
- S208
-
561 Safety and pharmacokinetics of the now nucleoside polymerase inhibitor, HCV-796: Results of a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjectsChandra, P. / Raible, D. / Moyer, L. / Harper, D. / Speth, J. / Villano, S. / Fruncillo, R. et al. | 2006
- S210
-
566 Pharmacokinetics and pharmacodynamics of induction doses of peginterferon alpha-2a (40KD) (PEGASYS®) and ribavirin (COPEGUS®) in HCV genotype 1 patients who failed to respond to interferon/ribavirinDiago, M. / Romero-Gomez, M. / Crespo, J. / Olveira, A. / Perez, R. / Barcena, R. / Sanchez-Tapias, J. M. / Munoz-Sanchez, M. et al. | 2006
- S212
-
572 Predictive value and predictive factors of the rapid virological response in chronic hepatitis C treatmentGaleras, J. A. / Gimé / nez, M. D. / Má / rouez, C. / Cirera, I. / Coll, S. / Solà / R. et al. | 2006
- S213
-
575 Retreatment with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in pegylated interferon α-2b (12KD)/ribavirin non-responders with cirrhosis/advanced fibrosis: Repeat interim analysisGitlin, N. / Jensen, D. / Di Bisceglie, A. / Berg, T. / Salmeron, J. / Rizzetto, M. / Yurdaydin, C. / Marcellin, P. et al. | 2006
- S214
-
578 Uptake of hepatitis C virus (HCV) treatment among injection drug users (IDUS) in Vancouver, CanadaGrebely, J. / Conway, B. / Raffa, J. / Lai, C. / Krajden, M. / Tyndall, M. W. et al. | 2006
- S215
-
581 Hepatitis C virus treatment in injecting drug users: Frequency of contraindications and prognostic markers in participants of the Swiss hepatitis C cohort studyDober, S. / Isler, M. / Meili, D. / Bruggmann, P. et al. | 2006
- S216
-
583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat studyJensen, D. / Andreone, F. / Benhamou, Y. / Horsmans, Y. / Diago, M. / Olveira Martins, A. / Teuber, G. / Rincon, D. / Marcellin, F. et al. | 2006
- S219
-
591 A prospective, multicenter, observational study on compliance to hepatitis C treatments (CHEOBS): Characteristics of HCV-infected patients with psychiatric disordersLang, J. P. / Meline, P. / Ouzan, D. / Cattan, L. / Chousterman, M. / Michels, R. / Fontanges, T. / Marcellin, P. / Cacoub, P. et al. | 2006
- S220
-
594 Natural course of treated and untreated chronic HCV infection: Results of the nationwide HEPNET. Greece cohort studyManesis, E. K. / Papatheodoridis, G. V. / Touloum, G. / Karafoulidou, A. / Ketikoglou, J. / Kitis, G. E. / Antoniou, A. / Kanatakis, S. / Koutsounas, S. J. / Vafiadis, I. et al. | 2006
- S221
-
597 Genotype and fibrosis stage are major predictors of sustained virological response to retreatment with pegylated combination in non responders to standard combination therapyMoukari, R. / Ripault, M. P. / Asselah, T. / Boyer, N. / Martinot, M. / El Ray, A. / Vidaud, D. / Cazals-Hatem, D. / Valla, D. / Marcellin, P. et al. | 2006
- S222
-
600 Association of metabolic syndrome, diabetes, iron metabolism and steatosis in HCV and HBV related chronic hepatitis: Differences and similaritiesMasarone, M. / La Mura, V. / Moschella, E. / Svelto, M. / Carrino, E. / Torella, R. / Persico, M. et al. | 2006
- S223
-
603 Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirinRomero-Gomez, M. / Tural, C. / Sola, R. / Martinez-Sierra, M. C. / Viloria, M. M. / Jimenez, M. D. / Arizcorreta, A. / Trabadela, C. / Clotet, B. / Planas, R. et al. | 2006
- S224
-
Alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment naive japanese chronic hepatitis C patients: A randomised, double-blind, multicentre, phase iii trialSakai, T. / Iino, S. / Okuno, T. / Omata, M. / Kiyosawa, K. / Kumada, H. / Yamada, G. / Hayashi, N. et al. | 2006
- S226
-
610 Antifibrotic effects of losartan administration in patients with chronic hepatitis CSookoian, S. / Ferná / ndez, M. A. / Castañ / o, G. O. et al. | 2006
- S227
-
613 Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirinTrapero-Marugan, M. / Garcia-Buey, L. / Muñ / oz, C. / Moreno-Monteagudo, J. A. / Borque, M. J. / Salcedo-Mora, X. / Moreno-Otero, R. et al. | 2006
- S230
-
620 Presence of CD4-positive cells in the portal tract on pretreatment liver biopsy is associated with early viral reduction during antiviral treatment of HCVWestin, J. / Lagging, M. / Romero, A. / Norkrans, G. / Pawlotsky, J. M. / Neumann, A. / Ferrari, C. / Schalm, S. / Zeuzem, S. / Negro, E. et al. | 2006
- S231
-
623 Safety and pharmacokinetics of NM107 following intravenous infusion of escalating doses in healthy volunteers: Determination of absolute oral bioavailability of valopicitabine (NM283)Zhou, X. J. / Knox, S. / Fielman, B. / Chao, G. / Brown, N. et al. | 2006
- S232
-
626 In vitro immunosuppressive effect of vitamin D3 in primary biliary cirrhosisAlmerighi, C. / Bogdanos, D. P. / Cholongitas, V. / Carey, I. / Meda, E. / Hussain, M. J. / Burroughs, A. K. / Vergani, D. et al. | 2006
- S233
-
629 Identification of new autoantigens on liver plasma membranes in type 1 autoimmune hepatitis by proteome analysisBallot, E. / Le Naour, F. / Tahiri, E. / Huguet, S. / Gigou, M. / Johanet, C. / Samuel, D. / Duclos Vallee, J. C. et al. | 2006
- S234
-
632 Four-year outcome of primary sclerosing cholangitis (PSC) under low-dose ursodeoxycholic acid (UDCA): A French prospective studyGarioud, A. / Seksik, P. / Chretien, Y. / Corpechot, C. / Poupon, R. / Poupon, R. E. / Chazouillè / res, O. et al. | 2006
- S235
-
635 High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effectiveCullen, S. N. / Rust, C. / Fleming, K. / Beuers, U. / Chapman, R. W. et al. | 2006
- S237
-
640 Alleviation of ConA immune mediated hepatitis via glycolipids: The role of beta versus alpha configuration in determining NKT lymphocyte distribution and the TH1/TH2 paradigmLalazar, G. / Preston, S. / Lador, A. / Panno, O. / Zolotarov, L. / Ilan, Y. et al. | 2006
- S238
-
643 Defective CD4+CD25+ T-regulatory cell ability to induce TGF-β secretion in autoimmune hepatitis is associated with reduced level of TGF-β gene expressionLonghi, M. S. / Mitry, R. R. / Mieli-Vergani, G. / Vergani, D. / Ma, Y. et al. | 2006
- S239
-
646 Once-weekly compared with daily alendronate for low bone mass in women with primary biliary cirrhosisPares, A. / Vazquez, I. / Alvarez, L. / Caballeria, L. / Pons, E. / Cerda, D. / Peris, E. / Monegal, A. / Guañ / abens, N. et al. | 2006
- S240
-
649 high frequency of X chromosome abnormalities in short stature women with unexplained elevated liver enzymesRoulot, D. / Malan, V. / Bourcier, V. / Benzacken, B. / Ziol, M. / Beaugrand, M. et al. | 2006
- S241
-
652 Juvenile autoimmune sclerosing cholangitis is associated with possession of HLA DRB1*13Underhill, J. / Liaskos, C. / Bogdanos, D. E. / Cheeseman, E. / Mieli-Vergani, G. / Vergani, D. / Mae, Y. et al. | 2006
- S244
-
662 Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patientsRiva, A. / Pelucchi, S. / Bovo, G. / Trombini, P. / Salvioni, A. / Mariani, R. / Vergani, A. / Casati, G. / Fargion, S. / Piperno, A. et al. | 2006
- S247
-
670 Morbidly obese patients with or whitout nash and type 2 diabetes have increased inflammatory C-reactive protein in both liver and adipose tissueAnty, R. / Bekri, S. / Luciani, N. / Saint Paul, M. C. / Dahman, M. / Iannelli, A. / Ben Amor, I. / Staccini-Myx, A. / Huet, P. M. / Gugenheim, J. et al. | 2006
- S249
-
676 The fatty liver index: A simple and accurate predictor of hepatic steatosisCastiglione, A. / Bedogni, G. / Miglioli, L. / Crocè / L. S. / Masutti, E. / Passalacqua, M. / Bellentani, S. et al. | 2006
- S250
-
679 Prevalence and factors associated with nash and liver fibrosis in morbidly obese subjectsCressend, T. / Trouette, H. / Collet, D. / Sa Cunha, A. / Vergniol, J. / Blond, P. / Adhoute, X. / Masson, B. / de Ledinghen, V. et al. | 2006
- S251
-
682 Relationship between dietary intake and liver histology in non-alcoholic fatty liver diseaseFederico, A. / Trappoliere, M. / Coppola, E. / D'Auria, M. / Del Vecchio Blanco, C. / Loguercio, C. et al. | 2006
- S252
-
685 A role for p66shc and mitochondrial ROS in ethanol hepatotoxicity and alcoholic fatty liverKoch, O. R. / Fusco, S. / Palozza, P. / Larocca, L. M. / Cravero, A. / Farré / S. / Pani, G. / Galeotti, T. et al. | 2006
- S253
-
688 Non-invasive tests of liver fibrosis in NAFLD: A systematic reviewGuha, I. N. / Parkes, I. / Roderick, P. R. / Rosenberg, W. M. et al. | 2006
- S254
-
690 Statins in patients with elevated liver enzymes because of non-alcoholic fatty liver disease (NAFLD): A clinical and histopathological follow-up studyEkstedt, M. / Franzé / n, L. E. / Mathiesen, U. L. / Bodemar, G. / Kechagias, S. et al. | 2006
- S255
-
693 Manganese superoxide dismutase overexpression protects against hepatic mitochondrial dna depletion after an acute alcohol binge, yet aggravates mitochondrial DNA depletion after chronic alcohol intoxication in miceLarosche, I. / Letté / ron, P. / Fromenty, B. / Abbey-Toby, A. / Vadrot, N. / Feldmann, G. / Van Remmen, H. / Richardson, A. / Pessayre, D. et al. | 2006
- S256
-
696 Simultaneous presence of tumor necrosis factor receptor 2 and tumor necrosis factor promoter gene polymorphisms associates with alcoholic liver diseaseMachado, M. V. / Martins, A. / Cortez-Pinto, H. / Almeida, R. / Marques-Vidal, P. / Gonç / alves, M. S. / Carneiro de Moura, M. / Camilo, M. E. et al. | 2006
- S257
-
699 Nateglinide improves non-alcoholic steatohepatitis (NASH) with type 2 diabetesMorita, Y. / Ueno, T. / Sasaki, N. / Tateishi, Y. / Nagata, E. / Kage, M. / Sata, M. et al. | 2006
- S258
-
702 Liver peroxisomes release H2O2 into the cytoplasm via microtubules: Direct evidence for peroxisomes as essential oxidative stress sourceFritz, R. / Bol, J. / Aneermuller, S. / Fahimi, H. D. / Volkl, A. / Mueller, S. et al. | 2006
- S259
-
705 Screening of severe liver fibrosis in the general population and by GPOberti, E. / Cailliez, E. / Fouchard-Hubert, I. / Robin, B. / Gallois, Y. / Rabouin, F. / Ternisien, C. / Dubois, E. / Lebot, B. / Soulard, G. et al. | 2006
- S260
-
7088 A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD)Puri, P. / Baillie, R. A. / Wiest, M. / Mirshahi, F. / Sanyal, A. J. et al. | 2006
- S261
-
711 Pentoxifylline protects genetically obese mice from ethanol-induced hepatic apoptosisRobin, M. A. / Demeilliers, C. / Sutton, A. / Paradise, V. / Maisonneuve, C. / Dubois, S. / Poirel, O. / Letté / ron, P. / Pessayre, D. et al. | 2006
- S262
-
714 Hypoadiponectinemia is associated with insulin resistance in patients with non-hfe related hepatic iron overloadSalvioni, A. / Corbetta, S. / Trombini, P. / Vergani, A. / Coletti, S. / Beck-Peccoz, P. / Spadal, A. / Piperno, A. et al. | 2006
- S263
-
737 Circulating and adipose tissue expression of visfatin in non-alcoholic fatty liver diseaseSoardol, G. / Pagano, C. / Donnini, D. / Pilone, C. / Domenis, L. / Azzolini, R. / Olivieri, M. / Milocco, C. / Vettor, R. / Sechi, L. et al. | 2006
- S265
-
722 Identification and characterization of homo sapiens submergence induced protein 2 (ESIP-L) in NAFLD: A diagnostic and molecular approachTsimako, M. E. / Kroon, P. / Wilce, P. et al. | 2006
- S266
-
725 Liver involvement in acute vaso-occlusive crisis of patients with sickle cell disease: Prevalence and predisposing factorsSevastos, N. / Koskinas, J. / Zacharakis, G. H. / Galiatsos, N. / Manesis, E. / Archimandritis, A. J. et al. | 2006
- S271
-
736 Early clearance of HCV RNA with valopicitabine (NM283) plus PEG-Interferon in treatment-naïve patients with HCV-1 infection: First results from a phase IIb trialDieterich, D. / Lawitz, E. / Nguyen, T. / Younes, Z. / Santoro, J. / Gitlin, N. / McEniry, D. / Chasen, R. / Goff, J. / Knox, S. et al. | 2006
- S273
-
740 Emergence of dual-resistance HBV mutations to adefovir-dipivoxil and lamivudine in a hepatitis B patient with combination therapy for adefovir resistanceKwon, S. Y. / Lee, C. H. / Choi, W. H. / Yeon, J. E. / Byun, K. S. et al. | 2006
- S276
-
747 Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis BNaoumov, N. / Lai, C. L. / Gane, E. / Liaw, Y. E. / Thongsawat, S. / Wang, Y. / Heathcote, E. J. / Rasenack, J. / Bzowej, N. / Chao, G. et al. | 2006
- S277
-
749 A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIA clinical trialSchneider, J. / Halota, W. / Delic, D. / Nesic, Z. / Prokopowicz, D. / Flisiak, R. / Kuydowicz, J. / Jankowski, M. / Cianciara, J. / Mach, T. et al. | 2006
- S279
-
Author index| 2006
- XXI
-
Subject Index| 2006
-
Editorial Board| 2006
-
18 Differential priming of T cells by antigens expressed in hepatocytes and cholangiocytes in animal models of autoimmune hepatitis and cholangitisDerkow, K. / Vierich, S. / Kruse, N. / Klugewitz, K. / Mintern, J. / Wiedenmann, B. / Berg, T. / Ploegh, H. / Schott, E. et al. | 2006
-
30 Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the eurotransplant allocation systemAdler, M. / Lerut, J. / Starkel, P. / Van Vlierberghe, H. / Troisi, R. / De Pauw, F. / Fancello, A. / Bonduel, G. / De Gendt, E. / Vereerstraeten, P. et al. | 2006
-
46 Prevalence of hepatitis B in France, 2003–2004Meffre, C. / Le Strat, Y. / Delarocque-Astagneau, E. / Lemasson, J. M. / Coste, D. / Steinmetz, J. / Antona, D. / Dubois, F. / Warszawski, J. / Meyer, J. F. et al. | 2006
-
57 Colocalization of HCV core protein with intracellular lipid droplets occurs regardless of the HCV genotype and the steatogenic character of HCV strainsPiodi, A. / Chouteau, P. / Christov, C. / Hé / zode, C. / Pawlotsky, J. M. et al. | 2006
-
69 Local circulation of VEGF is involved in collateral vessels development in cirrhotic patients with portal hypertensionIavarone, M. / Iannuzzi, F. / Manenti, E. / Fabris, F. / Dell Era, A. / Petazzi, G. / Primignani, M. / de Franchis, R. / Colombo, M. et al. | 2006
-
146 Use of a 13C methacetin breath test (MBT) for follow-up of patients with acute liver diseaseLalazar, G. / Shuvy, M. / Pappo, O. / Hajaj, T. R. / Margalit, M. et al. | 2006
-
152 Post transplant metabolic syndrome (PTMS): A novel definition among liver transplant recipientsLaryea, M. / Watt, K. D. / Molinari, M. / Walsh, M. / Peltekian, K. M. et al. | 2006
-
163 Underestimated impact of alcohol consumption on the progression of fibrosis in patients transplanted for HCV related cirrhosis: A comparative study with patients transplanted for alcohol-related cirrhosisSobesky, R. / Francoz, C. / Boudjema, H. / Paradis, V. / Dondero, F. / Belghiti, J. / Valla, D. / Marcellin, P. / Durand, F. et al. | 2006
-
192 αvβ6 Integrin: an epithelial marker of fibrosis progression and a novel antifibrotic target in experimental and human liver fibrosisPatsenker, E. / Popov, Y. / Stickel, F. / Mayer, B. / Niedobitek, G. / Schuppan, D. et al. | 2006
-
231 Terlipressin and albumin therapy for patients with advanced cirrhosis and severe renal failureSerrano, M. / Pascasio, J. M. / Sousa, J. M. / De la Santa, E. / Sayago, M. / Ferrer, M. T. / Má / rquez, J. L. / Garzó / n, M. et al. | 2006
-
236 The role of somatostatin and octreotide in preventing the post endoscopic increase of HVPG in cirrhotics with bleeding varicesVlachogiannakos, J. / Kougioumtzian, A. / Triantos, C. / Viazis, N. / Sgouros, S. / Saveriadis, A. / Manolakopoulos, S. / Markoglou, C. / Gouma, E. / Economopoulos, T. et al. | 2006
-
239 Surveillance program for early detection of hepatocellular carcinoma in japan. Result of specialized department of liver diseaseAndo, E. / Kuromatsu, R. / Tanaka, M. / Fukushima, N. / Takada, A. / Sumie, S. / Nagaoka, S. / Inoue, K. / Akiyoshi, J. / Kurogi, J. et al. | 2006
-
251 A sirna targeted against srf reduces hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumourFarra, R. / Pozzato, G. / Dapas, B. / Agostini, E. / Scaggiante, B. / Guarnieri, G. / Colombo, M. / Grassi, G. et al. | 2006
-
290 A role of IFN-α in the double-stranded RNA degradation during Fas-ligand induced liver apoptosis and balance between proliferation and deathKocic, G. / Jevtovic, T. / Pavlovic, D. / Bjelakovic, G. / Kocic, R. et al. | 2006
-
294 Tauroursodeoxycholic acid inhibits C282y HFE-induced activation of endoplasmic reticulum stressLawless, M. W. / Norris, S. et al. | 2006
-
324 Regulation of suppressor of cytokine signaling 3 mrna stability by TNF-α involves activation of the MKK6/P38MAPK cascadeEhlting, C. / Schaper, E. / Brenndö / rfer, E. D. / Matthes, R. J. / Heinriche, P. C. / H↑ / ssinger, D. / Bode, J. G. et al. | 2006
-
342 Discovery of genes associated with apoptosis of hepatic stellate cells using the ribozyme library systemTakei, Y. / Kawakubo, Y. / Yamashina, S. / Enomoto, N. / Okubo, H. / Sato, N. et al. | 2006
-
345 BcI-2 overexpression in human activated hepatic stellate cells: A survival and pro-fibrogenic mechanismCannito, S. / Novo, E. / Zamara, E. / Valfrè / di Bonzo, L. / DeFranco, R. / Mazzocca, A. / Colombatto, S. / Marra, E. / Autelli, R. et al. | 2006
-
353 Des-gamma-carboxy prothrombin (DCP) promotes vascular endothelial cell proliferation and migration through VEGRFR2-PLCγ-MAPK signaling pathwayFujikawa, T. / Shiraha, H. / Suzuki, M. / Ueda, N. / Takaoka, N. / Nakanishi, Y. / Sakaguchi, K. / Shiratori, Y. et al. | 2006
-
354 Growth arrest-specific protein 6 (GAS6) promotes liver tissue repair after an acute toxic injuryLafdil, F. / Deveaux, V. / Chobert, M. N. / Brouillet, A. / Zafrani, E. S. / Mavier, P. / Nakano, T. / Laperche, Y. et al. | 2006
-
357 Macrophage activation promotes invasive properties of hepatocellular carcinoma cells through destablization of the E-cadherin/ B-catenin complexLin, C. J. / Lin, C. Y. / Wu, J. C. / Huang, S. H. / Wang, S. M. / Chen, G. H. et al. | 2006
-
372 Hepatic gene induction in bone marrow after hepatectomyYamazaki, S. / Miki, K. / Takayama, T. / Hasegawa, K. / Sata, M. / Midorikawa, Y. / Aburatani, H. / Makuuchi, M. et al. | 2006
-
383 High volume hydrodynamic injection of plasmid DNA via the hepatic artery achieved a high level of gene expression in rat hepatocellular carcinoma induced diethylnitrosoamineTada, M. / Hatano, E. / Taura, K. / Nitta, T. / Koizumi, N. / Uyama, N. / lkai, I. / Shimahara, Y. et al. | 2006
-
386 Levels of virus replication and liver inflammation are inversely correlated with the intensity of HBV-specific T cell responses in anti-HBe+ chronic hepatitis BBoni, C. / Fisicaro, P. / Di Vincenzo, P. / Giuberti, T. / Mori, C. / Zerbini, A. / Missale, G. / Ferrari, C. et al. | 2006
-
389 Virus control within families of children vertically infected by hepatitis B depends on both host immune response and virus ability to mutateCarey, I. / Bansal, S. / Longhi, M. S. / Ma, Y. / Meda, F. / Byrne, J. A. / Mieli-Vergani, G. / Vergani, D. et al. | 2006
-
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutantsFlichman, D. / Moriconi, F. / Oliveri, F. / Ciccorossi, P. / Coco, B. / Colombatto, P. / Sacco, R. / Bonino, F. / Brunetto, M. R. et al. | 2006
-
432 Interferon alpha-stimulated genes response in chronic hepatitis C patients treated by IFN alpha and ribavirin: Relationships with viral kineticsLeroy, V. / Thelu, M. A. / Behan, S. / Dufeu-Duchesnne, T. / O'Farrelly, C. / Zarski, J. P. et al. | 2006
-
433 Identification of a novel nuclear target antigen in hepatitis C and B virus chronic infectionsLiaskos, C. / Bogdanos, D. P. / Rigopoulou, E. / Mieli-Vergani, G. / Dalekos, G. N. / Vergani, D. et al. | 2006
-
441 The influence of interleukin- 10 promoter gene polymorphism on the occurrence of non hodgkin lymphoma (NHL) in subjects infected with hepatitis C virus (HCV)Persico, M. / Capasso, M. / Persico, E. / La Mura, V. / Masarone, M. / Svelto, M. / Iolascon, A. et al. | 2006
-
457 Determinants of hepatitis B viral load and its decline over time: A community-based follow-up studyChen, C. J. / Chen, E. J. / Yang, H. I. / Iloeje, U. H. / Su, J. / Yeh, S. H. / Jen, C. L. / You, S. L. / Chen, D. S. et al. | 2006
-
467 Primary adefovir resistance mutations in patients with YMDD mutation and resistance to lamivudine: The incidence and clinical courseLee, J. H. / Kim, D. Y. / Lee, D. H. / Choi, M. S. / Koh, K. C. / Paik, S. W. / Lee, J. S. / Yoo, B. C. et al. | 2006
-
476 Reasons for the lack of anti-HBc antibody detection in hepatitis B virus infected patientsAvettand-Fenoel, V. / Katlama, C. / Povnard, T. / Thibault, V. et al. | 2006
-
478 Enotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patientsSu, C. W. / Huang, Y. H. / Huo, T. I. / Shih, H. H. / Sheen, I. J. / Chen, S. W. / Lee, E. C. / Lee, S. D. / Wu, J. C. et al. | 2006
-
490 High barrier to resistance results in no emergence of entecavir resistance in nucleoside-naïve subjects during the first two years of therapyColonno, R. J. / Rose, R. E. / Baldick, C. J. / Levine, S. M. / Klesczewski, K. / Tenney, D. J. et al. | 2006
-
534 Complement factor 5 is no genetic risk factor for the progression of liver fibrosis in chronic hepatitis C infectionHalangk, J. / Sarrazin, C. / Puhl, G. / Teuber, G. / Klinker, H. / Buggisch, P. / Hinrichsen, H. / Weich, V. / Bergk, A. / Wiedenmann, B. et al. | 2006
-
540 Hospital admission is the only epidemiological risk factor in most cases of acute hepatitis CMartinez-Bauer, E. / Foms, X. / Armelles, M. / Planas, R. / Sola, R. / Vergara, M. / Fabregas, S. / Vega, R. / Salmeron, J. / Buti, M. et al. | 2006
-
546 Early HCV-RNA decline in peripheral blood mononuclear cells predicts SVR versus relapse in chronic hepatitis C patients treated with pegylated interferon-α plus ribavirinPugnale, P. / Neumanne, A. U. / Pawlotsky, J. M. / Zeuzem, S. / Negro, F. et al. | 2006
-
554 Detection of subclinical depression with qualified self-rating questionnaires in chronic Hepatitis C patients predicts depression during interferon treatmentTsiolakidou, G. / Koulentaki, M. / Mamalakis, G. / Matrella, E. / Kafatos, A. / Kouroumalis, E. A. et al. | 2006
-
568 Efficacy and safety of the treatment with peginterferon alpha-2a (PEGASYS®) plus ribavirin in patients with chronic hepatitis C genotype 4: Interim resultsDiago, M. / Boadas, J. / Planasi, R. / Solá / R. / del Olmo, J. A. / Crespo, J. / Erdozaid, J. C. / Antó / n, M. D. et al. | 2006
-
569 Incidence and predictive factors of psychiatric Disorders before and during treatment of chronic hepatitis C (CHC) with pegylated IFN α −2a and ribavirin: Prospective studyCastellví / P. / Dí / ez-Quevedo, C. / Miquel, M. / Naviné / s, R. / Solere, A. / Gimé / nez, M. D. et al. | 2006
-
573 Early virological response (EVR) and viral kinetics during the first 12 weeks of antiviral treatment in HCV-HIV co-infected patients: Control studyGaleras, J. A. / Tural, C. / Gimé / nez, M. D. / Má / rquez, C. / Rubio, R. / Santí / n, M. / Fuster, D. et al. | 2006
-
574 Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patientsRamose, B. / Nuñ / ez, M. / Rendon, A. / Romero, M. / Sheldon, J. / Barreiro, P. / Martin-Carbonero, L. / Morenò / A. et al. | 2006
-
590 Economic evaluation of early monotherapy versus delayed combination therapy in patients with acute hepatitis CDintsios, C. M. / Haverkamp, A. / Wiegand, J. / Gerlach, T. / Grü / ner, N. / Wedemeyer, H. / Pape, G. R. / Manns, M. P. / Krauth, C. et al. | 2006
-
595 Evidence for eradication of HCV, assessed with transcription mediated amplification (TMA), in chronic hepatitis C patients with sustained virological response to therapyMaylin, S. / Martinot-Peignoux, M. / Boyer, N. / Ripault, M. P. / Fé / ray, C. / Nicolas-Chanoine, M. H. / Marcellin, P. et al. | 2006
-
608 Impact of treatment for hepatitis C infection in clinical practiceScognamiglio, E. / Cuzzi, G. / Iezzi, L. / Bove, G. / Conte, T. / Croce, G. E. et al. | 2006
-
612 Chronic hepatitis C in patients with end stage renal disease: Characterization of liver histology and response to interferon therapy before renal transplantationTeixeira, R. / Almeida, R. L. / Silva, A. H. / Brandõ / R. S. / Espindola, T. C. / Oliveira, M. L. / Cambraia, R. D. / Figueiredo, E. M. / Medeiros Junior, W. et al. | 2006
-
622 Efficacy and safety of peginterferon alpha-2a (40KD) [PEG] plus ribavirin [RBV] 1000/1200 mg/d in genotype 1 patients with chronic hepatitis C and ‘normal’ ALT levelsZehnter, E. / Mauss, S. / John, C. / Heyne, R. / Mö / ller, B. / Lutz, T. / Bokemeyer, B. / Kihn, R. / Moog, G. et al. | 2006
-
627 Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancyAzzaroli, E. / Mennone, A. / Feletti, V. / Simoni, P. / Magliuolo, M. / Baglivo, E. / Rizzo, N. / Lodato, E. / Festi, D. / Colecchia, A. et al. | 2006
-
647 Genetic variants of hepatobiliary transporter and nuclear receptor genes and response to ursodeoxycholic acid in primary biliary cirrhosisBarbu, V. / Ping, C. / Corpechot, C. / Chré / tien, Y. / Matsuda, E. / Chazouilliè / res, O. / Simon, T. / Poupon, R. E. et al. | 2006
-
651 Intrahepatic CD4+ lymphocytes trapping during tolerance induction using mushroom derived formulations: A possible role for the liver in tolerance inductionShuvy, M. / Hershcovici, T. / Zolotarov, L. / Ilan, Y. et al. | 2006
-
656 Non-alcoholic fatty liver disease in obese childrenGoicoechea, A. / Ferná / ndez, J. M. / Ocete, E. / Garofano, M. / Gila, A. / Palacio, A. / Salmerö / n, J. / Ruiz Extremera, A. et al. | 2006
-
664 HFE gene mutations and Wilson's disease in SardiniaSorbello, O. / Sini, M. / Acquas, C. / Faa, G. / Demelia, L. et al. | 2006
-
672 protein C activity predicts NAFLD independently of classic risk factors, metabolic syndrome, and C-reactive proteinAssy, N. / Davidov, V. / Grozovski, M. / Mejiriski, Y. / Schlesinger, S. / Hussein, O. et al. | 2006
-
686 Comparison of two clinical scales in the causality assessment of drug induced liver diseaseGarcí / a-Corté / s, M. / Pachkoria, K. / Lucena, M. I. / Andrade, R. / Camargo, R. / Alcantara, R. / Hidalgo, R. et al. | 2006
-
706 NASH with pericentral fibrosis and neutrophil inflammation in mice overexpressing 11α-Hydroxysteroid-Dehydrogenase (HSD-1) in adipose tissuePopov, Y. / Mueller, S. / Turner, B. / Zinkin, N. / Nasser, I. / Masuzaki, H. / Viereck, J. / Hamilton, J. / Flier, J. / Afdhal, N. et al. | 2006
-
712 Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytesRobin, M. A. / Sauvage, I. / Grandperret, T. / Descatoire, V. / Pessayre, D. / Fromenty, B. et al. | 2006
-
713 Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease patients: Double-blind placebo-controlled studySakata, R. / Ueno, T. / Nakamura, T. / Hashimoto, O. / Sakamoto, M. / Torimura, T. / Sata, M. et al. | 2006
-
724 Gene expression in hepatic and white adipose tissues of patients with obesity-related non-alcoholic steatohepatitis (NASH)Collantes, R. / Baranova, A. / Schlauch, K. / Gowder, S. / Del Giacco, L. / Elarinyl, H. / Van Meter, A. / Afendy, A. / Ong, J. E. / Goodman, Z. et al. | 2006
-
734 Peginterferon alpha-2a (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks in patients with HCV genotype 2 OR 3. Final results of the accelerate trialShiffman, M. L. / Pappas, S. / Nyberg, L. / Greenbloom, S. / Gibas, A. / Bacons, B. / Rasenack, J. / Suter, F. / Diago, M. / Lin, A. et al. | 2006
-
751 The safety and efficacy of viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naïve patients infected with HCV: Phase 3 resultsBenhamou, Y. / Pockros, P. / Rodrieuez-Torres, M. / Gordon, S. / Shiffinan, M. / Lurie, Y. / Afdhal, N. / Lamon, K. / Kim, Y. / Murphy, B. et al. | 2006
-
12 Wild-type HCV NS3 protease re-emerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCVKieffer, T. / Sarrazin, C. / Bartels, D. / Hanzelka, B. / Mü / h, U. / Welker, M. / Wincheringer, D. / Lin, C. / Purdy, S. et al. | 2006
-
39 Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegifn/RBV) re-treatment in hepatitis patients with prior non-response to PEGIFN/RBV: Week 24 resultsAfdhal, N. / O Brien, C. / Godofsky, E. / Rodriguez-Torres, M. / Pappas, S. C. / Pockros, P. / Lawitz, E. / Bzowej, N. / Rustgi, V. / Sulkowski, M. et al. | 2006
-
54 Cellular binding and entry of hepatitis C virus pseudotypes and virus-like particles requires a different set of cellular co-receptorsHaberstroh, A. / Barth, H. / Schnober, E. K. / Pestka, J. M. / Diepolder, H. M. / Gerlach, J. T. / Patel, A. H. / Blum, H. E. / Cosset, F. / Baumert, T. F. et al. | 2006
-
56 Scavenger receptor class B type i mediates uptake and cross-presentation of hepatitis C virus by human dendritic cellsBarth, H. / Schnober, E. K. / Neumann-Haefelin, C. / Thimme, R. / Blum, H. E. / Baumert, T. F. et al. | 2006
-
66 Endogenous opioids stimulate hsc activity in a paracrine manner during the development of liver fibrosisSvegliati Baroni, G. / De Minicis, S. / Marzioni, M. / Casini, A. / Salzano, R. / Saccomanno, S. / Benedetti, A. et al. | 2006
-
72 Expression of cytoglobin by adeno-associated virus-2 gene transfer inhibits hepatic stellate cell activation and liver fibrosis in toxic and cholestatic models of liver injuryXu, R. / Harrison, P. M. / Chen, M. / Li, L. / Tsui, T. / Fung, P. C. / Cheung, P. / Wang, G. / Diao, Y. / Krissansen, G. W. et al. | 2006
-
90 Hepatic mitochondrial free cholesterol accumulation in the Niemann-pick C diseaseMari, M. / Caballero, F. / Colell, A. / Garcia-Ruiz, C. / Fernandez-Checa, J. C. et al. | 2006
-
92 Prediction of mortality in severe alcoholic hepatitis: Validation of lille model and comparison to other prognostic scoresLouvet, A. / Diaz, E. / Texier, F. / Dharancy, S. / Boitard, J. / Biron, N. / Plane, C. / Deltenre, P. / Hollebecque, A. / Canva, V. et al. | 2006
-
93 Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identifiedAndrade, R. J. / Lucena, M. I. / Pachkoria, K. / Borraz, Y. / Pelaez, G. / Jimé / nez, M. / Rodrigo, L. / Romero-Gomez, M. / Planas, R. et al. | 2006
-
95 Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate dependent and involves AE2 anion exchangerBanales, J. M. / Arenas, F. / Rodriguez-Ortigosa, C. M. / Sá / ez, E. / Uriarte, I. / Doctor, R. B. / Prieto, J. / Medina, J. F. et al. | 2006
-
102 Sphingosine-1-phosphate triggers wound healing via the S1P2 receptor following acute liver injurySerriere-Lanneau, V. / Teixeira-Clerc, F. / Schippers, M. / de Vries, W. / Julien, B. / Tran-Van-Nhieu, J. / Poelstra, K. / Chun, J. / Mallat, A. / Lotersztajn, S. et al. | 2006
-
112 Vascular hypocontractility to angiotensin-II in human and experimental cirrhosis is not related to changes in AT1-receptorexpression, but associated with overexpression of receptor-desensitizing proteinsHennenberg, M. / Trebicka, J. / Hack, G. / Biecker, E. / Schepke, M. / Sauerbruch, T. / Heller, J. et al. | 2006
-
117 The stimulation of purinergic P2Y receptors promotes hepatocyte preconditioning via a SRC and p38 map kinase-dependent mechanismCarini, R. / De Cesaris, M. G. / Alchera, E. / Splendore, R. / Piranda, D. / Baldanzi, G. / Albano, E. et al. | 2006
-
170 Muscle atrophy in advanced cirrhosis: A neglected factor in the evaluation of regional hemodynamicsCaraceni, P. / Dazzani, F. / Salizzoni, E. / Domenicali, M. / Zambruni, A. / Trevisani, F. / Bernardi, M. et al. | 2006
-
172 Heparinase I, II and III modified thromboelastography for the detection of different glycosaminoglycans' effect in cirrhotics with bacterial infectionSenzolo, M. / Cholongitas, E. / Riddell, A. / Coppell, J. / Thalheimer, U. / Burroughs, A. K. et al. | 2006
-
174 Opposite effects of immortalized met murine hepatocytes on cell cycle and cell fate of rat liver hepatic stellate cells and liver myofibroblastsDudas, J. / Novosiadlyy, R. / Aprighano, I. / Saile, B. / Bordoni, V. / Elmaouhoub, A. / Tripodi, M. / Ramadori, G. et al. | 2006
-
182 Protein oxidation in astrocyte of porto-caval shunted rats: Role of oxidative stress in hepatic encephalopathyJover, M. / Diaz-Gó / mez, D. / Fontiveros, E. / Collantes de Terá / n, L. / Parrado, J. / Camacho, I. / Bautista, J. / Romero-Gomez, M. et al. | 2006
-
212 Management of digestive bleeding related to portal hypertension in cirrhotic subjects: Impact of the paris consensus statementCharpigno, C. / Oberti, F. / Bernard, P. / Bartoli, E. / Pauwels, A. / Renard, P. / Cadranel, J. E. / Chabert, B. B. / Barbare, J. C. / Ingrand, I. et al. | 2006
-
211 Synergic action of insulin-like growth factor I (IGF-I) and interferon-α (IFNα) co-administration in experimental cirrhosisCastilla-Cortá / za, I. / Tutau, E. / Puche, J. E. / Garcí / a-Ferná / ndez, M. / Mirpur, E. / Castilla, A. / Quiroga, J. et al. | 2006
-
225 Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy people: A prospective study in potential living related liver donorsKim, K. M. / Park, S. H. / Yu, E. S. / Lee, S. G. / Lim, Y. S. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006
-
264 Identification of new markers of hepatocellular carcinoma from sera of patients with chronic liver diseases by proteomic pattern discriminationKim, Y. J. / Yoon, J. H. / Lee, H. S. et al. | 2006
-
273 Therapeutic outcomes of radiofrequency ablation (RFA) under general anesthesia for hepatocellular carcinoma (HCC)Saito, A. / Chiba, M. / Haruyama, K. / Nozawa, H. / Shiratori, K. / Katagiri, S. / Katsuragawa, H. / Yamamoto, M. / Takasaki, K. et al. | 2006
-
272 Immunomagnetic isolation and amplification of AFP-specific T-cell populations: A first step towards immunotherapy for hepatocellular carcinomaRichou, C. / Pichard, V. / Geboes, K. / Gaignerie, A. / Masliah, C. / Conchon, S. / Gournay, J. / Ferry, N. et al. | 2006
-
361 Mechanisms of liver regeneration after extensive hepatectomy by plateletsMurata, S. / Matsuo, R. / Ikeda, O. / Ohkohchi, N. et al. | 2006
-
365 The hepatoprotective role of ketanserin in acute cadmium liver injuryPanoutsopoulos, G. I. / Tzirogiannis, K. N. / Papadimas, G. K. / Skaltsas, S. D. / Demonakou, M. D. / Hereti, R. I. / Manta, G. A. / Mykoniatis, M. G. et al. | 2006
-
408 RNA interference against the regulatory 3′-untranslated region efficiently inhibits HCV subgenomic replicon replicationKorf, M. / Meyer, A. / Manns, M. P. / Krü / ger, M. et al. | 2006
-
409 dating the HCV3a epidemic in greece using molecular clock approachesMagiorkinis, G. / Magiorkinis, E. / Paraskevis, D. / Vassilakis, A. / Issaris, C. / Papatheodoridis, G. V. / Tassopoulos, N. C. / Hatzakis, A. et al. | 2006
-
505 Conversion of liver transplant recipients with hepatitis B virus from hepatitis B immune globulin (HBIG) and lamivudine (LAM) to adefovir dipivoxil (ADV) and LAMNeff, G. W. / Zacharias, V. C. / Alonzo, M. / Kenner, N. / Weber, E. / Kaiser, T. E. / Safdar, K. / Rideman, E. / Thomas, M. / Martin, J. et al. | 2006
-
521 Clinical significance of anti-HBc as the only marker of hbv infection in general population. A cohort study with an observational period of up to 12 yearsZacharakis, G. H. / Koskinas, J. / Papoutselis, M. / Tzara, E. / Vafeiadis, N. / Maltezos, E. / Karayiannis, P. / Archimandritis, A. J. / Papoutselis, K. / Kotsiou, S. et al. | 2006
-
551 Hepatitis C virus-associated B cell proliferation: A key role for serum B lymphocyte stimulator (BLYS/BAFF)Sene, D. / Limal, N. / Ghillani-Dalbin, P. / Saadoun, D. / Piette, J. C. / Cacoub, P. et al. | 2006
-
606 Effect of peginterferon alpha-2b and ribavirin on histological lesions in patients with hepatitis C virus (HCV) and HCV/HIV co-infection: An open-label trialSarmento e Castro, R. / Horta, A. / Coelho, H. / Vasconcelos, O. / Mé / ndez, J. / Seabra, J. / Tavares, A. P. / Fortes, O. / Duarte, M. et al. | 2006
-
631 Influence of the predisposing DRB1*08 allele and of the protective HLA-DRB1*11 allele over the expression of primary biliary cirrhosis-specific anti-mitochondrial and anti-nuclear reactivitiesInvernizzi, P. / Bogdanos, D. P. / Bianchi, I. / Meda, E. / Liaskos, C. / Burroughs, A. K. / Zuin, M. / Vergani, D. et al. | 2006
-
634 Assessment of biliary fibrosis by transient elastography in PBC and PSC patientsCorpechot, C. / El Naggar, A. / Poujol-Robert, A. / Ziol, M. / Wendum, D. / Chazouillè / res, O. / de Ledinghen, V. / Dhumeaux, D. / Marcellin, P. et al. | 2006
-
695 Prevalence and risk factors for non-alcoholic fatty liver disease in potential living liver donors in Korea: 589 consecutive biopsies review in single centerLee, J. Y. / Kim, K. M. / Lee, S. G. / Lim, Y. S. / Lee, H. C. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2006